- Home
- Software Solutions
- Resources
- Corporate
Abbott Laboratories
Abbott Laboratories Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Agitation Dementia | >Depakote ER >Seroquel | Phase_III | Depakote Extended Release... | NCT00315900 |
| Active | Psoriasis | >adalimumab >adalimumab | Phase_II Phase_III | Adalimumab in Adult Japan... | NCT00647400 |
| Active | Schizophrenia | >ABT-288 >Placebo >ABT-288 | Phase_II | Efficacy and Safety Study... | NCT01077700 |
| Active | Cardiogenic Shock Septic Shock | >Levosimendan >Dobutamine | Phase_II Phase_III | Levosimendan Versus Dobut... | NCT00093301 |
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >ZoMaxxâ„¢ Drug-Eluting Coronary Stent System >TAXUSâ„¢ EXPRESS2â„¢ Paclitaxel Eluting Coronary Stent | Phase_II | Safety and Efficacy of th... | NCT00140101 |
| Active | Malnutrition | >Nepro with Carb Steady >Standard of Care | Phase_IV | DaVita Assessment of Nutr... | NCT00895401 |
| Active | Rheumatoid Arthritis | >Adalimumab >Adalimumab >Placebo | Phase_III | Efficacy and Safety of Ad... | NCT00195702 |
| Active | Rheumatoid Arthritis | >Placebo >Adalimumab 80 mg >Adalimumab 40 mg | Phase_II Phase_III | A Study to Assess the Saf... | NCT00538902 |
| Active | Moderate to Severe Plaque Psoriasis | >ABT-874 | Phase_III | Open Label Continuation S... | NCT00626002 |
| Active | Chronic Kidney Disease Vitamin D Coronary Calcification Bone Metabolism | >Calcitriol (Rocaltrol®) >Paricalcitol | Phase_IV | Vitamin D and Coronary Ca... | NCT00752102 |
| Active | Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis | EValuation of HumIRA® in... | NCT01078402 | ||
| Active | Secondary Hyperparathyroidism Chronic Kidney Disease | >Paricalcitol >Calcitriol | Phase_IV | Paricalcitol Versus Calci... | NCT00823303 |
| Active | Acute Heart Failure | Determining When Patients... | NCT00911703 | ||
| Active | Axial Spondyloarthritis | >Adalimumab >Placebo >Open-label Adalimumab | Phase_III | Study of Adalimumab in Su... | NCT00939003 |
| Active | Secondary Hyperparathyroidism Hemodialysis | >paricalcitol >maxacalcitol | Phase_II | Paricalcitol Compared to ... | NCT00990704 |
| Active | Respiratory Tract Infection | >clarithromycin (Klacid XL) | Clarithromycin Study for ... | NCT01075204 | |
| Active | Ankylosing Spondylitis | >Adalimumab 40 mg sc every other week | Phase_II Phase_III | D2E7-Early AS | NCT00235105 |
| Active | Solid Tumor | >ABT-263 >paclitaxel >Carboplatin | Phase_I | Safety Study of ABT-263 i... | NCT00891605 |
| Active | Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis Endothelial Dysfunction Inflammatory Disease Activity | Endothelial Function, Inf... | NCT00902005 | ||
| Active | Rheumatoid Arthritis | >adalimumab (Humira) | Safety and Effect on Qual... | NCT01076205 | |
| Active | HIV Infection | >Different formulations of once-daily lopinavir/ritonavir | Phase_IV | A Multicenter Study to As... | NCT00281606 |
| Active | Acquired Immune Deficiency Syndrome | >Lopinavir-ritonavir >Efavirenz | Phase_IV | Immune Reconstitution of ... | NCT00775606 |
| Active | Coronary Artery Disease | >XIENCE V® | Evaluation of a XIENCE VÂ... | NCT00987506 | |
| Active | Acute Myocardial Infarction | >Autologous, Unfractionated Bone Marrow Mononuclear Cells | Phase_I | Bone Marrow Stem Cell Inf... | NCT00268307 |
| Active | Brain Neoplasms Neoplasm Metastasis Central Nervous System Diseases Brain Diseases Nervous System Neoplasms | >ABT-888 >Whole Brain Radiation Therapy | Phase_I | A Phase I Study of ABT-88... | NCT00649207 |
| Active | Coronary Artery Disease | >Everolimus-eluting stent (Xience or Promus) >Sirolimus-eluting stent (Cypher) >6-month clopidogrel therapy >12-month clopidogrel therapy | Phase_IV | Efficacy of Xience/Promus... | NCT00698607 |
| Active | Azotemia Renal Insufficiency, Chronic Renal Failure, Acute Hydronephrosis | Sensitivity and Specifici... | NCT00786708 | ||
| Active | Skin Cancer Melanoma Metastatic Melanoma | >temozolomide >ABT-888 >Placebo | Phase_II | A Study Evaluating Effica... | NCT00804908 |
| Active | Solid Tumor | >ABT-263 >Docetaxel | Phase_I | Safety Profile, MTD, and ... | NCT00888108 |
| Active | Hip Fracture | >Medical Food Supplement >standard hospital food | Phase_III | Effect of a Medical Food ... | NCT01011608 |
| Active | Hepatitis C, HCV, Chronic Hepatitis C, Hepatitis C Genotype 1 | >ABT-450 >ABT-072 >ABT-333 >ritonavir >pegIFN >ribavirin | Phase_II | A Randomized Study to Eva... | NCT01074008 |
| Active | Lymphoma Lymphoma, Follicular | >ABT-263 | Phase_I Phase_II | A Study of ABT-263 in Sub... | NCT00406809 |
| Active | HIV Infection | >lopinavir/ritonavir (LPV/r) >emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) >raltegravir (RAL) | Phase_III | Study Comparing Lopinavir... | NCT00711009 |
| Active | Arthritis, Rheumatoid | >adalimumab >methotrexate | Phase_IV | A Pilot Study of the Feas... | NCT00808509 |
| Active | Alzheimer's Disease | >Placebo >ABT-126 >donepezil | Phase_II | Efficacy and Safety Study... | NCT00948909 |
| Active | Crohn's Disease | >Treatment Algorithm for Crohn's Disease | Phase_IV | Trial of a Treatment Algo... | NCT01030809 |
| Active | Pain | >Hydrocodone/acetaminophen extended release >Morphine Extended Release >Acetaminophen >Placebo | Phase_II | Hydrocodone/Acetaminophen... | NCT01038609 |
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V® Everolimus Eluting Coronary Stent >TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent | Phase_III | SPIRIT II: A Clinical Eva... | NCT00180310 |
| Active | Juvenile Idiopathic Arthritis | >adalimumab >Methotrexate | Juvenile Idiopathic Arthr... | NCT00783510 | |
| Active | Coronary Occlusion | >Percutaneous coronary intervention (PCI) | Phase_IV | Guidewire for Chronic Tot... | NCT00987610 |
| Active | Psoriatic Arthritis | >adalimumab (Humira) | Safety and Effectiveness ... | NCT01078610 | |
| Active | Human Immunodeficiency Virus | >Lopinavir/Ritonavir (Kaletra) | 3 Years Long-time Follow ... | NCT01083810 | |
| Active | Coronary Disease Coronary Artery Disease Coronary Artery Stenosis Coronary Artery Restenosis | >Coronary artery placement of a drug-eluting stent >Coronary artery placement of a drug-eluting stent | Phase_IV | EXecutive: Evaluating XIE... | NCT00531011 |
| Active | Spinal Muscular Atrophy | >Valproic Acid (VPA) >Placebo | Phase_II | Valproic Acid in Ambulant... | NCT00481013 |
| Active | Alcoholic Liver Disease (ALD) | >S-adenosylmethionine >placebo | Phase_III | Effects of SAMe in Patien... | NCT00573313 |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 >FCR >BR | Phase_I | Study of ABT-263 When Adm... | NCT00868413 |
| Active | Secondary Hyperparathyroidism Renal Insufficiency, Chronic Parathyroid Hormone Hemodialysis Hypercalcemia | >Zemplar | Phase_IV | Effectiveness and Safety ... | NCT00891813 |
| Active | Psoriasis | >Methotrexate >Adalimumab (Humira) | Mechanism of Action Study... | NCT00932113 | |
| Active | HIV Infections | >Kaletra (lopinavir/ritonavir) >Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine) | Phase_II Phase_III | Prevention of HIV1 Mother... | NCT00424814 |
| Active | Coronary Artery Disease Chronic Kidney Disease Hypovitaminosis D Secondary Hyperparathyroidism | >paricalcitol >placebo | Phase_III | Effect of Vitamin D Suppl... | NCT01012414 |
| Active | HIV Infections | >Kaletra + Isentress >Standard HAART Regimen | Phase_IV | Kaletra-isentress Treatme... | NCT00700115 |
| Active | Bipolar Disorder | >Divalproex >Placebo Divalproex | Phase_III | Double-Blind, Placebo-Con... | NCT00194116 |
| Active | HIV Infection | >MEMS cap monitoring >MEMS cap monitoring >MEMS cap monitoring | Phase_IV | A Trial to Determine the ... | NCT00785616 |
| Active | Healthy | >ABT-384 | Phase_I | A Study of ABT-384 Levels... | NCT01009216 |
| Active | Advanced Solid Tumors | >veliparib (ABT-888) >carboplatin >gemcitabine | Phase_I | A Study of ABT-888 in Com... | NCT01063816 |
| Active | Refractive Error | Performance and Acceptabi... | NCT01067716 | ||
| Active | Rheumatoid Arthritis | Cost Utility Analyses of ... | NCT01078116 | ||
| Active | HIV | >Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC | Phase_IV | Clinical Study of an Aluv... | NCT01088516 |
| Active | Non-hematologic Malignancies Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma | >ABT-888 >Temozolomide | Phase_I | A Phase I Study of ABT-88... | NCT00526617 |
| Active | Puberty, Precocious | >Leuprolide acetate 11.25 mg >Leuprolide acetate 30 mg | Phase_III | A Study of Leuprolide 11.... | NCT00635817 |
| Active | Dyslipidemias Coronary Heart Disease Kidney Disease | >ABT-335 >Rosuvastatin >Placebo | Phase_III | 30 Week Study of the Comb... | NCT00680017 |
| Active | Foot Ulcer, Diabetic | >Medical Food >Drink mix calorically similar to experimental product | Phase_III | Evaluation of a Medical F... | NCT00711217 |
| Active | Kidney Failure, Acute Kidney Failure, Chronic Cardiac Surgical Procedures | >N-acetylcysteine >fenoldopam | Phase_II | An Investigation of N-Ace... | NCT00122018 |
| Active | Epilepsy | >Compliance | Phase_IV | Compliance With Once-Dail... | NCT00356018 |
| Active | Asthma | >SKP FlutiForm HFA pMDI | Phase_III | A Phase 3, Multicenter, O... | NCT00747318 |
| Active | Spondyloarthritis Crohn's Disease | >Adalimumab | Phase_IV | Effectiveness and Safety ... | NCT00972218 |
| Active | HIV Infections Acquired Immunodeficiency Syndrome | >lopinavir/ritonavir plus maraviroc | Phase_IV | Pilot Assessment of Lopin... | NCT00981318 |
| Active | Senile Dementia, Alzheimer Type Dementia, Alzheimer Type Alzheimer Disease Dementia | >risperidone >quetiapine >olanzapine >divalproex | Phase_IV | A Comparison of Two Stand... | NCT00208819 |
| Active | Coronary Restenosis | >Xience V® | Phase_III | Clinical Evaluation of Pa... | NCT00882219 |
| Active | Advanced Hepatocellular Carcinoma | >ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00517920 |
| Active | Coronary Artery Disease | >XIENCE V® Everolimus Eluting Coronary Stent | Phase_IV | XIENCE V® Everolimus Elu... | NCT00676520 |
| Active | Cataract | >Viscoelastic | Phase_III | Clinical Evaluation of a ... | NCT00972621 |
| Active | Pathological Gambling Obsessive Compulsive Disorder | >fMRI | Functional Magnetic Reson... | NCT00211822 | |
| Active | HIV Infections | >Kaletra Tablets | Phase_III | Kaletra Monotherapy in HI... | NCT00508222 |
| Active | Prostate Cancer | >ABT-888 >temozolomide | Phase_I | A Study Combining ABT-888... | NCT01085422 |
| Active | Hand Osteoarthritis | >Adalimumab (Humira®) >Placebo | Phase_III | Efficacy Study of an Anti... | NCT00597623 |
| Active | HIV Infections | >Lopinavir/ritonavir simplification strategy | Phase_IV | Induction-Maintenance of ... | NCT00159224 |
| Active | Plaque Atherosclerotic Disease Heart Disease Stroke | BioImage Study: A Clinica... | NCT00738725 | ||
| Active | HIV Infections HIV-Associated Lipodystrophy Syndrome | >Lopinavir/ritonavir + zidovudine + lamivudine >Lopinavir/ritonavir + nevirapine | Phase_IV | MEDICLAS Study (Metabolic... | NCT00122226 |
| Active | HIV Infections | >Lopinavir/ritonavir and tenofovir | Phase_IV | Kaletra and Viread in Ant... | NCT00679926 |
| Active | Rheumatoid Arthritis | >Humira (adalimumab) + methotrexate >Placebo + methotrexate | Phase_IV | A Study to Determine the ... | NCT00420927 |
| Active | Cataract | >modified light transmission intraocular lens >ZA9003 monofocal acrylic intraocular lens | Phase_III | Safety and Efficacy of a ... | NCT00747227 |
| Active | Osteoporosis | >Fructooligosaccharide | Phase_I Phase_II | Fructooligosaccharide and... | NCT01005927 |
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V® Everolimus Eluting Coronary Stent | Phase_IV | XIENCE V® Everolimus Elu... | NCT00631228 |
| Active | Chronic Lymphocytic Leukemia Lymphomas Leukemias | >ABT-263 >ABT-263 >ABT-263 | Phase_I | Oral Bioavailability and ... | NCT00743028 |
| Active | Coronary Artery Disease | >everolimu-eluting stent >coronary artery bypass graft surgery | Phase_IV | Bypass Surgery Versus Eve... | NCT00997828 |
| Active | Psoriasis | Greek Study of the Qualit... | NCT01077128 | ||
| Active | Angina Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V / PROMUS stent placement | XIENCE V/PROMUS Everolimu... | NCT01086228 | |
| Active | Elderly Epilepsy Seizures | >Divalproex Sodium Extended-Release Tablets | Tolerability and Efficacy... | NCT00318929 | |
| Active | Ulcerative Colitis | >adalimumab >placebo | Phase_III | Efficacy and Safety of Ad... | NCT00408629 |
| Active | Respiratory Syncytial Infection Prematurity Bronchopulmonary Dysplasia Chronic Heart Disease | >palivizumab | Phase_II Phase_III | Palivizumab for Preventio... | NCT01006629 |
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >Bioabsorbable Everolimus Eluting Coronary Stent | Phase_III | ABSORB Clinical Investiga... | NCT00300131 |
| Active | Metabolic Syndrome X | >Metformin and fenofibrate >Metformin >fenofibrate >Metformin and Fenofibrate placebo | Phase_II | The Fenofibrate and Metfo... | NCT00400231 |
| Active | Critical Illness Starvation Enteral Nutrition | >Data Collection >Nutritional management protocol | Phase_IV | ICU Nutrition Study Bern | NCT00574431 |
| Active | HIV-1 Infections | >Lopinavir/ritonavir (Kaletra) | Clinical, Virological and... | NCT01074931 | |
| Active | Crohn's Disease | >adalimumab >Placebo | Phase_II Phase_III | A Study of Adalimumab for... | NCT00445432 |
| Active | Peripheral Vascular Disease | >Absolute Proâ„¢ Peripheral Self-Expanding Stent System >Omnilink Eliteâ„¢ Peripheral Balloon-Expandable Stent System | Phase_III | Trial to Evaluate the Saf... | NCT00844532 |
| Active | Moderate to Severe Plaque Psoriasis | >adalimumab (Humira) | Documentation of Humira i... | NCT01077232 | |
| Active | Rheumatoid Arthritis | A 3-year Study Following ... | NCT01086033 | ||
| Active | Dementia | >Depakote | Phase_I | Study of Depakote for Beh... | NCT00197834 |
| Active | Cystic Fibrosis | >Biaxin ( clarithromycin) | Macrolide Antibiotic Ther... | NCT00205634 | |
| Active | Advanced or Metastatic Non-Small Cell Lung Cancer | >ABT-869 >Placebo | Phase_II | Study of Carboplatin/Pacl... | NCT00716534 |
| Active | Ulcerative Colitis | >adalimumab >adalimumab >placebo | Phase_III | Efficacy and Safety of Ad... | NCT00385736 |
| Active | Human Immunodeficiency Virus | >Lopinavir/Ritonavir (Kaletra) | 3 Years/5 Years Long-time... | NCT01083836 | |
| Active | Low Back Pain | >Interspinous process and dynamic stabilization >Conservative Care | Phase_III | Wallis Mechanical Normali... | NCT00134537 |
| Active | Insulin Resistance Hypertriglyceridemia | >Rosiglitazone >Fenofibrate >Weight Loss | Comparing Tricor, Avandia... | NCT00186537 | |
| Active | Carotid Artery Disease | >RX ACCULINK, RX ACCUNET Embolic Protection System | Phase_IV | CAPTURE 2 Post-Marketing ... | NCT00302237 |
| Active | Crohn's Disease | >adalimumab | A 5-Year Registry Study o... | NCT00524537 | |
| Active | Glaucoma | >Tube shunt surgery >Trabeculectomy with mitomycin C | Primary Tube Versus Trabe... | NCT00666237 | |
| Active | HIV Infections | >lopinavir/ritonavir and raltegravir | Phase_IV | Safety Study of Lopinavir... | NCT00752037 |
| Active | Juvenile Idiopathic Arthritis | >Adalimumab | Phase_III | Active Juvenile Idiopathi... | NCT00775437 |
| Active | Asthma | >ABT-308 >ABT-308 >Placebo >Placebo | Phase_I | Assessment of the Safety ... | NCT00986037 |
| Active | Carotid Artery Disease Carotid Stenosis Stroke Atherosclerosis | >Carotid artery stenting with filter (interventional) >Carotid artery endarterectomy (surgical) | Phase_III | Carotid Stenting vs. Surg... | NCT00106938 |
| Active | Advanced Renal Cell Carcinoma | >ABT-869 | Phase_II | Study of ABT-869 in Subje... | NCT00486538 |
| Active | Coronary Artery Stenosis Coronary Arteriosclerosis Coronary Artery Disease Coronary Artery Restenosis Total Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia | >XIENCE V®/ XIENCE PRIME™ >Randomized sub-study | Phase_IV | XIENCE V: SPIRIT WOMEN | NCT00496938 |
| Active | Coronary Artery Disease | >Placebo & Aspirin >Clopidogrel & Aspirin, Prasugrel & Aspirin | Phase_IV | The Dual Antiplatelet The... | NCT00977938 |
| Active | Secondary Hyperparathyroidism Chronic Kidney Disease | >paricalcitol iv (Zemplar iv) | Study of Zemplar iv in Pa... | NCT01084538 | |
| Active | Giant Cell Arteritis | >adalimumab >placebo | Phase_III | HECTHOR: Humira to Spare ... | NCT00305539 |
| Active | Carotid Artery Disease | >Xact Stent with either Emboshield Pro or Emboshield (Gen 3) | Protected Carotid Artery ... | NCT00402740 | |
| Active | Type 1 Diabetes | >Navigator® >Navigator® >Placebo | Are the Continuous Glucos... | NCT00726440 | |
| Active | Esophageal Cancer | >Prosure >Ensure Plus | Phase_IV | Trial of Enteral Nutritio... | NCT00790140 |
| Active | Renal Artery Obstruction Hypertension, Renal | >Herculink Elite Renal Stent System | The HERCULES Trial - A Sa... | NCT00490841 | |
| Active | Arthritis, Juvenile Idiopathic | >Adalimumab >Placebo | Phase_III | Study of the Human Anti-T... | NCT00048542 |
| Active | HIV AIDS | >Kaletra (drug) | High Dose Ritonavir/Lopin... | NCT00247143 | |
| Active | HIV Infections | >2 NRTI + 1 PI/r + Maraviroc + Raltegravir >2 NRTI + 1 PI/r + Maraviroc + Raltegravir | New Era Study: Treatment ... | NCT00908544 | |
| Active | Stents Neointimal Proliferation | >Percutaneous coronary intervention with stent implantation | Phase_IV | Optical Coherence Tomogra... | NCT01056744 |
| Active | Advanced Prostate Cancer Lower Urinary Tract Symptoms | >Leuprolide acetate Depot Susp. 11,25 mg (Poland), 3,75 mg (Ukraine) | Lucrin® Depot Efficacy a... | NCT01078545 | |
| Active | Chronic Kidney Disease Left Ventricular Hypertrophy | >paricalcitol >placebo | Phase_III | The PRIMO Study-Paricalci... | NCT00497146 |
| Active | Puberty, Precocious | >Leuprolide acetate 11.25 mg >Leuprolide acetate 30 mg | Phase_III | Safety Extension Study Of... | NCT00667446 |
| Active | Osteoarthritis, Knee | >PG110 (anti-nerve growth factor monoclonal antibodyPlacebo to match PG110 >Placebo | Phase_I | Safety and Tolerability o... | NCT00941746 |
| Active | Coronary Artery Disease | >XIENCE V® Everolimus Eluting Coronary Stent >TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent | Phase_III | SPIRIT IV Clinical Trial:... | NCT00307047 |
| Active | Arthritis, Rheumatoid | >Adalimumab >Placebo | Phase_III | Optimized Treatment Algor... | NCT00660647 |
| Active | Type 2 Diabetes | >Dietary >Physical Activity >Self-Regulatory Approaches | Development of Self-Regul... | NCT00941447 | |
| Active | Genetic Disorders | Reproducibility of the Ar... | NCT00214448 | ||
| Active | Coronary Artery Disease | >Xience/Promus >Cypher | Registry to Evaluate Effi... | NCT00960648 | |
| Active | Solid Tumors Small Cell Lung Carcinoma | >ABT-263 >etoposide/cisplatin | Phase_I | A Study Evaluating the Sa... | NCT00878449 |
| Active | Healthy | >ABT-450 >ritonavir >ABT-450 | Phase_I | Study in Healthy Adults t... | NCT01091649 |
| Active | Renal Insufficiency Secondary Hyperparathyroidism | >Zemplar (paricalcitol) | Long-Term Therapy Outcome... | NCT01083849 | |
| Active | Rheumatoid Arthritis | >Adalimumab (up to 5 years exposure) | Phase_III | Long Term Open Label Cont... | NCT00195650 |
| Active | HIV Infections | >Lopinavir/ritonavir (drug) | Phase_III | Comparison of Treatment S... | NCT00140751 |
| Active | Secondary Hyperparathyroidism Chronic Kidney Disease | >Paricalcitol >Ergocalciferol | Phase_IV | Vitamin D Deficiency in C... | NCT00958451 |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 >rituximab | Phase_II | A Study of ABT-263 in Com... | NCT01087151 |
| Active | Angina, Unstable | Phase_IV | Diagnosis and Treatment o... | NCT00222352 | |
| Active | Sarcoidosis | >adalimumab | Phase_II | A Study of Adalimumab to ... | NCT00274352 |
| Active | Glaucoma | >Baerveldt glaucoma implant >Trabeculectomy with mitomycin C | Tube Versus Trabeculectom... | NCT00306852 | |
| Active | Prostatic Neoplasms | >Endorectal Coil Magnetic Resonance Images | Phase_II | Endorectal Coil Magnetic ... | NCT00160953 |
| Active | Uveitis | >Adalimumab | Phase_II Phase_III | Adalimumab in Uveitis Ref... | NCT00348153 |
| Active | Stent Thrombosis Clopidogrel Aspirin Bleeding Angioplasty | VerifyNow French Registry | NCT00753753 | ||
| Active | Respiratory Tract Infection | >Clarithromycin (Klacid® MR) | Recovery Time in Thai Pat... | NCT01076153 | |
| Active | Carotid Artery Disease | >RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 | Phase_IV | CHOICE: Carotid Stenting ... | NCT00406055 |
| Active | Ankylosing Spondylitis | >adalimumab | Phase_III | A Study of Adalimumab in ... | NCT00667355 |
| Active | Hidradenitis Suppurativa | >adalimumab >Placebo | Phase_II | Study of Adalimumab in Su... | NCT00918255 |
| Active | Active Rheumatoid Arthritis Osteoporoses | Effectiveness of Adalimum... | NCT01078155 | ||
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >ZoMaxxâ„¢ Drug-Eluting Coronary Stent System >TAXUSâ„¢ EXPRESS2â„¢ Paclitaxel Eluting Coronary Stent System | Phase_II Phase_III | Safety and Efficacy of th... | NCT00148356 |
| Active | Prostate Cancer | >Leuprorelin Acetate >Zoledronic Acid >Conventional external beam therapy | RADAR Trial - Randomised ... | NCT00193856 | |
| Active | Obesity Post-gastric Bypass | >receive amino acid supplement | Nutritional Effect of an ... | NCT00473356 | |
| Active | Percutaneous Intervention Via Femoral Artery | >StarClose® >AngioSeal® | Phase_IV | Star-Close Versus Angio-S... | NCT00590356 |
| Active | HIV Infections | >Kaletra + Isentress >Atripla | Phase_II | Raltegravir + Lopinavir/R... | NCT00752856 |
| Active | Restenosis | The ITALIC Study: Is Ther... | NCT00780156 | ||
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >Bioabsorbable Everolimus Eluting Coronary Stent | Phase_I Phase_II | ABSORB Clinical Investiga... | NCT00856856 |
| Active | Peripheral Spondyloarthritis | >adalimumab >placebo >adalimumab | Phase_III | Study of Adalimumab in Su... | NCT01064856 |
| Active | AIDS-Related Kaposi's Sarcoma | >abacavir/3TC/zidovudine >abacavir /3TC plus ritonavir boosted lopinavir | Phase_II Phase_III | A Pilot Study Of the Effe... | NCT00834457 |
| Active | Solid Tumor | >ABT-263 >gemcitabine | Phase_I | Safety Study of ABT-263 i... | NCT00887757 |
| Active | Kidney Transplant | >Paricalcitol | Oral Paricalcitol in Kidn... | NCT00587158 | |
| Active | Lymphoma Chronic Lymphocytic Leukemia Solid Tumors | >ABT-263 >Ketoconazole | Phase_I | A Phase 1 Study to Assess... | NCT01021358 |
| Active | Schizophrenia | >ABT-126 >Placebo for ABT-126 | Phase_I | Pharmacokinetic Study of ... | NCT01043458 |
| Active | Rheumatoid Arthritis | >adalimumab (Humira) | Efficacy and Safety of Ad... | NCT01077258 | |
| Active | Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis | >HUMIRA (adalimumab) | Belgian Registry of HUMIR... | NCT01078558 | |
| Active | HIV Infections | >Kaletra | Phase_IV | Kaletra Sex/Gender Pharma... | NCT00148759 |
| Active | HIV Infections | >Lopinavir/r plus saquinavir | Phase_IV | A PK and Salvage Study fo... | NCT00476359 |
| Active | Rheumatoid Arthritis | Drug Use Investigation fo... | NCT01076959 | ||
| Active | Crohn's Disease Rheumatoid Arthritis | OTIS Autoimmune Diseases ... | NCT01086059 | ||
| Active | HIV-Associated Lipodystrophy Syndrome | >nucleoside analogue sparing HAART regimen | Phase_IV | Comparing a Nucleoside-An... | NCT00135460 |
| Active | Irritable Bowel Syndrome | >Itopride HCl 50 mg >Itopride HCl 100 mg >Placebo | Phase_II | Study to Evaluate the Rol... | NCT01027260 |
| Active | Rheumatoid Arthritis | Clinical Outcomes Complia... | NCT01083160 | ||
| Active | Psoriasis Vascular Inflammation Coronary Atherosclerosis | >adalimumab >UVB Phototherapy >Topical treatment | Phase_IV | Effect of Adalimumab on V... | NCT00940862 |
| Active | Secondary Hyperparathyroidism Chronic Kidney Disease Stage V Cardiac Morbidity | Study to Evaluate the Eff... | NCT01073462 | ||
| Active | Early Rheumatoid Arthritis | >Adalimumab >Methotrexate >Adalimumab placebo >Methotrexate placebo | Phase_III | Efficacy and Safety of Ad... | NCT00195663 |
| Active | HIV Infections | >Ritonavir-boosted lopinavir and raltegravir >Ritonavir-boosted lopinavir and 2N(t)RTI | Phase_IV | A Trial of 2 Options for ... | NCT00931463 |
| Active | Coronary Artery Disease | >XIENCE V >CYPHER | Phase_IV | Randomized Comparison of ... | NCT00997763 |
| Active | Delirium | >dexmedetomidine >midazolam >propofol | Phase_IV | Is Dexmedetomidine Associ... | NCT00417664 |
| Active | Retinopathy of Prematurity | >carotenoids | Skin and Serum Carotenoid... | NCT00872664 | |
| Active | HIV Infections | >Truvada (tenofovir/emitricitabine) >Kaletra (lopinavir/ritonavir) | Phase_IV | Immune Reconstitution as ... | NCT00885664 |
| Active | Diabetic Nephropathy Chronic Kidney Disease | >Placebo for Atrasentan 0,2 mg/mL solution >0.25 mg Atrasentan QD >0.75 mg Atrasentan QD >1.75 mg Atrasentan QD | Phase_II | A Study of Atrasentan on ... | NCT00920764 |
| Active | Infant | >Infant Formula milk based >Infant formula milk based | Phase_IV | Comparative Ca Absorption... | NCT00941564 |
| Active | Myopia Hyperopia Astigmatism | >Complete Easy Rub Formula MPS >Aquify MPS | Phase_III | Complete Easy Rub Compara... | NCT01019564 |
| Active | Vaginal Odor | >WaterWorks Douching Device | Efficacy of (WaterWorks®... | NCT00417365 | |
| Active | Cataract | >Tecnis ZM900 Multifocal Intraocular Lens | Safety and Effectiveness ... | NCT00747565 | |
| Active | Cognitive Function in Carotid Stenting | Assessment of Cognitive F... | NCT00919165 | ||
| Active | Atherosclerosis | Individualized Comprehens... | NCT00969865 | ||
| Active | Coronary Artery Disease | Same Day Discharge After ... | NCT01054365 | ||
| Active | Type 2 Diabetes | >SMBG to guide clinical decisions >SMBG and CGM | Modal Day Analysis of Sel... | NCT01072565 | |
| Active | Chronic Kidney Failure Secondary Hyperparathyroidism | Follow-up Patients With E... | NCT01081665 | ||
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | PROSPECT: An Imaging Stud... | NCT00180466 | ||
| Active | Lower Respiratory Tract Infection Respiratory Syncytial Virus Infections | Phase_IV | Utilization and Complianc... | NCT00420966 | |
| Active | Atherosclerosis Peripheral Vascular Disease | >Dynalink®-E everolimus-eluting peripheral stent >Dynalink®-E, everolimus-eluting peripheral stent | A Safety and Efficacy Stu... | NCT00475566 | |
| Active | Lymphoma Chronic Lymphocytic Leukemia Solid Tumors | >ABT-263 >ABT-263 >ABT-263 >ABT-263 | Phase_I | Assess the Oral Bioavaila... | NCT00982566 |
| Active | Lower Respiratory Tract Infection | >clarithromycin (Klacid®) granules for oral suspension | Recovery Time in Children... | NCT01076166 | |
| Active | Rheumatoid Arthritis | >Adalimumab >Placebo | Phase_III | A Study of Adalimumab in ... | NCT00870467 |
| Active | Moderate to Severe Plaque Psoriasis | A Post Marketing Observat... | NCT01084668 | ||
| Active | Non-Tuberculous Mycobacteria Mycobacterium Avium Complex | >Clarithromycin | Phase_IV | Clarithromycin for the Tr... | NCT00600769 |
| Active | Diabetes Mellitus, Type 2 | >standard nutritional product (medical food) >nutritional product for diabetes (medical food) >diabetes specific experimental nutritional product (medical food) | Phase_III | Comparison of Nutritional... | NCT00797069 |
| Active | HIV Infections | >Kaletra and Intelence Tablets | Phase_IV | A Pilot Study of Kaletra ... | NCT01045369 |
| Active | Abdominal Aortic Aneurysm | >PEVAR (ProGlide closure) >SEVAR (IntuiTrak) >PEVAR (Prostar XL closure) | Phase_II | Trial of Percutaneous End... | NCT01070069 |
| Active | Lung Cancer | >Nutritional Assessment >EPA-DHA arm | Phase_II Phase_III | Effect on the Nutritional... | NCT01048970 |
| Active | Chronic Kidney Disease Stage 5 | >paricalcitol | Phase_III | Evaluate Safety and Effic... | NCT01071070 |
| Active | Human Immunodeficiency Virus | >Lopinavir/Ritonavir (Kaletra) | 5 Year Long-time Follow-u... | NCT01081470 | |
| Active | Premature Infants | Compliance to Synagis (Pa... | NCT01077271 | ||
| Active | Rheumatoid Arthritis | >adalimumab (Humira) | Safety and Effectiveness ... | NCT01078571 | |
| Active | Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania | >Divalproex >Placebo | Phase_III | Study of Divalproex Exten... | NCT00278772 |
| Active | Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V® Everolimus Eluting Coronary Stent >TAXUS™ LIBERTÉ™ Paclitaxel Eluting Coronary Stent | Phase_IV | SPIRIT V: Post-Marketing ... | NCT00402272 |
| Active | Pressure Ulcers | >Nutritional Supplement/Amino acids and HMB | Phase_I Phase_II | Effect of an Oral Supplem... | NCT00502372 |
| Active | Dyslipidemias Carotid Artery Disease Coronary Heart Disease | >ABT-335 >Placebo | Phase_III | Safety and Efficacy Study... | NCT00616772 |
| Active | Human Immunodeficiency Virus | Drug Use Investigation of... | NCT01076972 | ||
| Active | Juvenile Rheumatoid Arthritis | >adalimumab | Phase_III | Safety, Efficacy, and Pha... | NCT00690573 |
| Active | Critical Illness | >Freestyle Navigator | Continuous Glucose Monito... | NCT00694473 | |
| Active | Coronary Artery Disease Carotid Artery Diseases Atherosclerosis | >Atorvastatin >Extended Release Niacin >Colesevelam >Placebo Niacin >Placebo Colesevelam | Phase_IV | Using Magnetic Resonance ... | NCT00715273 |
| Active | Drug-Eluting Stents | Xience V at WFUBMC | NCT00937573 | ||
| Active | Lymphoma Chronic Lymphocytic Leukemia Solid Tumors | >ABT-263 >erlotinib >irinotecan | Phase_I | A Study Evaluating ABT-26... | NCT01009073 |
| Active | HIV Infections | >lopinavir/ritonavir plus maraviroc | Phase_IV | Kaletra and Maraviroc in ... | NCT01068873 |
| Active | Prostatic Neoplasm | >leuprolide (Lucrin/Lucrin-Tri-depot) | A Study to Document Treat... | NCT01081873 | |
| Active | Cardiac Catheterization | >suture mediated closure | Characteristics Predictiv... | NCT00838175 | |
| Active | Chronic Kidney Disease | >Paricalcitol >Placebo | Phase_II | Metabolic Effects of Pari... | NCT01003275 |
| Active | Alzheimer's Disease | >ABT-288 >donepezil >placebo | Phase_II | Efficacy and Safety Study... | NCT01018875 |
| Active | Epilepsy Behavioral Disturbance | >Rapid versus slow conversion | Phase_IV | Compare Tolerability of a... | NCT00312676 |
| Active | HIV Infections Hepatitis C | >LPV/r >Nucleoside Reverse Transcriptase Inhibitors >PEG-IFNa 2a >Ribavirin | Phase_III | Lopinavir/Ritonavir Monot... | NCT00437476 |
| Active | Pressure Ulcer | >Abound (7 g of Arginine, 7 g Glutamine and 1.2 g HMB) | The Use of Specialised Am... | NCT01090076 | |
| Active | Chronic Plaque Psoriasis | >HUMIRA® (adalimumab) | Post-marketing, Observati... | NCT00799877 | |
| Active | Type 2 Diabetes Currently Taking Metformin | >Continuous Glucose Monitoring of Carbohydrate Intake | Using Continuous Glucose ... | NCT00818077 | |
| Active | Stents Coronary Artery Disease Total Coronary Occlusion Coronary Artery Restenosis Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis | >XIENCE V® Everolimus Eluting Coronary Stent >TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent | Phase_III | SPIRIT III Clinical Trial... | NCT00180479 |
| Active | Kaposi's Sarcoma HIV Infections | >Lopinavir/ritonavir plus Emtricitabine/Tenofovir versus Efavirenz plus Emtricitabine/Tenofovir | Phase_IV | Anti-Retrovirals for Kapo... | NCT00444379 |
| Active | Secondary Hyperparathyroidism Dialysis | >Paricalcitol injection >Paricalcitol capsules | Phase_IV | Efficacy and Safety of 6 ... | NCT00537979 |
| Active | Chronic Kidney Disease | >paricalcitol | Oral Paricalcitol in Stag... | NCT00796679 | |
| Active | Hepatitis C | Clinical Performance of A... | NCT00979979 | ||
| Active | Human Immunodeficiency Virus | >lopinavir/ritonavir (Kaletra) | Kaletra in Combination Wi... | NCT01076179 | |
| Active | Solid Tumor | >ABT-869 | Phase_I | A Phase 1 Study of ABT-86... | NCT00718380 |
| Active | HIV Infections | >Isentress® >Celsentri® | Phase_III | IntensVIH: Impact Of Ther... | NCT00935480 |
| Active | Chronic Kidney Disease Secondary Hyperparathyroidism | >Paricalcitol Arm >Cinacalcet Arm | Phase_IV | Evaluation of the Effecti... | NCT00977080 |
| Active | Crohn's Disease | Contrast Enhanced Ultraso... | NCT01074580 | ||
| Active | Crohn´s Disease | >adalimumab (Humira) | Effectiveness and Safety ... | NCT01083680 | |
| Active | Respiratory Syncytial Viruses Respiratory Tract Infection | >Samples collection for viral diagnosis >Lung Function Analysis | Incidence of Severe Respi... | NCT00585481 | |
| Active | Flushing | >Quercetin >Placebo | Phase_IV | Advancing Niacin by Inhib... | NCT00913081 |
| Active | Aged | >Experimental Nutritional Powder Formula >Placebo comparator | Phase_I Phase_II | Evaluation of AN777 on El... | NCT00945581 |
| Active | Crohn's Disease | >adalimumab >adalimumab >adalimumab | Phase_III | Efficacy and Safety of Ad... | NCT00409682 |
| Active | HCV Infection | >Blood sample collection only | Phase_II | This is Follow-up Assessm... | NCT00726882 |
| Active | Infant, Newborn | >soy protein formula >Commercially available soy formula >Soy formula experimental #2 | Phase_II Phase_III | Comparative Gastrointesti... | NCT00798382 |
| Active | Ankylosing Spondylitis | >adalimumab (Humira) | Safety and Effectiveness ... | NCT01079182 | |
| Active | HIV Infections | A Comparison of Adherence... | NCT00432783 | ||
| Active | Hepatitis C | >ABT-072 >Placebo | Phase_I | A Study of Single Doses o... | NCT01081483 |
| Active | Rheumatoid Arthritis | >adalimumab | Phase_IV | Post-marketing Observatio... | NCT00234884 |
| Active | HIV Infections Hepatitis C | >LPV/r >PEG-IFNa 2a >Ribavirin >NUCS | Phase_III | Lopinavir/Ritonavir Monot... | NCT00437684 |
| Active | Lymphoproliferative Disorders | >ABT-263 >rituximab | Phase_I | Safety Study of ABT-263 i... | NCT00788684 |
| Active | Hypertension | Canadian Study of Trandol... | NCT01078584 | ||
| Active | Coronary Atherosclerosis | >sevoflurane >propofol | Phase_IV | TEAM-Project: Trial on th... | NCT00286585 |
| Active | Human Immunodeficiency Virus | Special Investigation of ... | NCT01076985 | ||
| Active | Depression, Bipolar | >Depakote ER | Phase_IV | Depakote ER in Bipolar De... | NCT00186186 |
| Active | Chronic Kidney Failure Secondary Hyperparathyroidism | Therapy With Oral Parical... | NCT01083186 | ||
| Active | Crohn's Disease | >Placebo >ABT-874 >ABT-874 | Phase_II | Dose Ranging Study Compar... | NCT00562887 |
| Active | Advanced or Metastatic Solid Tumors | >ABT-869 | Phase_I | Pharmacokinetic Study To ... | NCT00733187 |
| Active | Chronic Kidney Disease Stage 3 and 4 | >Zemplar (paricalcitol) Capsules >Placebo capsules | Phase_III | Safety and Efficacy of Pa... | NCT01020487 |
| Active | Breast Cancer Metastatic Breast Cancer | >ABT-888 >temozolomide | Phase_II | ABT-888 and Temozolomide ... | NCT01009788 |
| Active | HIV Mitochondrial Toxicity | >lopinavir/ritonavir; nevirapine; Zidovudine; Lamivudine | Phase_IV | NRTI-Sparing Pilot Study | NCT00143689 |
| Active | HIV Infections Hepatitis B Virus | Phase_IV | Multi-sponsor Registry to... | NCT00404989 | |
| Active | Advanced Colorectal Cancer | >ABT-869 >bevacizumab >oxaliplatin >folinic acid >fluorouracil >ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00707889 |
| Active | Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis Cardiovascular Disease | >BVS EESS | ABSORB EXTEND Clinical In... | NCT01023789 | |
| Active | Non-small Cell Lung Cancer (NSCLC) | >ABT-869 | Phase_II | Study of ABT-869 in Subje... | NCT00517790 |
| Active | HIV Infections | >Valproic Acid >raltegravir | Phase_I | Depletion of Latent HIV i... | NCT00576290 |
| Active | Rheumatoid Arthritis | >adalimumab (Humira) | Efficacy and Safety of Ad... | NCT01078090 | |
| Active | Chronic Lymphocytic Leukemia | >ABT-263 | Phase_I Phase_II | A Phase 1/2a Study of ABT... | NCT00481091 |
| Active | Human Immunodeficiency Virus | >Lopinavir/Ritonavir (Kaletra) | Kaletra: Therapy With Dou... | NCT01075191 | |
| Active | Solid Tumors | >bevacizumab, ABT-510 | Phase_I | A Phase I Study of ABT-51... | NCT00586092 |
| Active | Dyslipidemia | >Trilipix (fenofibric acid) >placebo | Phase_IV | Study of Trilipix Effects... | NCT01025492 |
| Active | Chronic Plaque Psoriasis | >adalimumab (HUMIRA) | Study of Adalimumab (HUMI... | NCT01076192 | |
| Active | Spondyloarthritis | >Adalimumab >Placebo | Phase_IV | Danish Multicenter Study ... | NCT00477893 |
| Active | Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma|Neoplasms, Glandular and Epithelial | >ABT-869 >Sorafenib | Phase_III | Efficacy and Tolerability... | NCT01009593 |
| Active | Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis | Quality of Life Outcomes ... | NCT01083693 | ||
| Active | HIV Infections | >Kaletra + Current Dual NRTI Backbone >Current Regimen | Phase_IV | A Research Study to See i... | NCT00145795 |
| Active | HIV Infection Pregnancy Breastfeeding HIV Infections | >Efavirenz-Tenofovir-Emtricitabine >Zidovudine-Lamivudine-Lopinavir/Ritonavir | Phase_III | Universal Use of EFV-TDF-... | NCT00936195 |
| Active | HIV Infections | >efavirenz/emtricitabin/tenofovir >lopinavir/ritonavir | Phase_II Phase_III | Evaluation of a Lopinavir... | NCT00946595 |
| Active | Colorectal Cancer | >Temozolomide and ABT-888 | Phase_II | A Study of ABT-888 in Com... | NCT01051596 |
| Active | Mycobacterium Avium Complex Lung Disease | >clarithromycin, rifabutin | Phase_IV | Use of Clarithromycin and... | NCT00598897 |
| Active | Rheumatoid Arthritis | >This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study. | A Study on the Prevalence... | NCT01078597 | |
| Active | Small Cell Lung Carcinoma Small Cell Lung Cancer | >ABT-263 | Phase_I Phase_II | A Phase 1/2a Study of ABT... | NCT00445198 |
| Active | HIV Infection Tuberculosis | >Rifampin | Phase_IV | An Evaluation of the Phar... | NCT00771498 |
| Active | Ulcerative Colitis | >adalimumab >placebo | Phase_II Phase_III | A Study of Adalimumab in ... | NCT00853099 |
| Active | Healthy Subjects | >SLV337 suspension >SLV337 capsule | Phase_I | 14-C ADME (Absorption, Di... | NCT01176201 |
| Active | Rheumatoid Arthritis | >adalimumab >methotrexate | Phase_III | Study to Determine the Ef... | NCT01185301 |
| Active | Non-small Cell Lung Cancer (NSCLC) | >Linifanib (ABT-869) >Linifanib (ABT-869) >Carboplatin >Paclitaxel | Phase_I | A Study of Linifanib (ABT... | NCT01225302 |
| Active | Mycobacterium Infections, Atypical | Special Investigation of ... | NCT01097005 | ||
| Active | Cataract | >One-Piece Tecnis Multifocal IOL, Model ZMB00 >One-Piece Tecnis monofocal IOL, Model ZCB00 | Phase_IV | Clinical Evaluation of th... | NCT01210807 |
| Active | Acid Peptic Disorders | >Buffered Pantoprazole >Buffered Pantoprazole | Phase_IV | Effect of Digene Total Bu... | NCT01214408 |
| Active | Cataract | >Tecnis ZCB00 IOL >Toric Intraocular lens | Phase_III | Clinical Evaluation of a ... | NCT01098812 |
| Active | Gastrointestinal Diseases Feeding Intolerance | >Peptide based enteral formula | Phase_III | Evaluation of the Safe Us... | NCT01191112 |
| Active | Healthy Term Infants | >Hydrolysate based infant formula >Investigational Infant Formula A >Investigational Infant Formula B | Phase_III | Tolerance of Healthy Term... | NCT01155414 |
| Active | Secondary Hyperparathyroidism End-Stage Renal Disease | Study to Evaluate Safety ... | NCT01134315 | ||
| Active | Osteoarthritis of the Knee | >ABT-652 >Placebo >Naproxen | Phase_II | A Study of ABT-652 in Adu... | NCT01207115 |
| Active | Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis | Study to Characterize Dem... | NCT01163916 | ||
| Active | Arthritis, Rheumatoid | >Adalimumab in the Physiolis syringe drug delivery device and in the currently FDA approved syringe drug delivery device >Adalimumab in the Physiolis autoinjector drug delivery device and in the currently FDA approved autoinjector drug deliv | Phase_II | The Usability & Injection... | NCT01163617 |
| Active | Hypogonadism | >Androgel® 1% | Phase_IV | ESPRIT Study in Hypogonag... | NCT01143818 |
| Active | Rheumatoid Arthritis | Special Investigation of ... | NCT01163318 | ||
| Active | Psoriasis | A Study of Effectiveness ... | NCT01126619 | ||
| Active | Refractive Astigmatism | >iFS Femtosecond Laser System | Phase_I | Feasibility of iFS for In... | NCT01210820 |
| Active | Arthritis Rheumatoid | >adalimumab >Methotrexate | Phase_IV | A Canadian Study to Evalu... | NCT01162421 |
| Active | Solid Tumor Cancers | >veliparib formulation A >veliparib formulation B >veliparib formulation C >veliparib formulation C | Phase_I | To Determine the Bioavail... | NCT01199224 |
| Active | Diabetes Mellitus | >FreeStyle Navigator Continuous Glucose Monitoring System | Use of the FreeStyle Navi... | NCT01214824 | |
| Active | Malnutrition Sarcopenia | >medical food with AN777 >oral nutritional formula | Phase_III | Evaluation of an Oral Nut... | NCT01191125 |
| Active | Alzheimer's Disease | >ABT-384 >donepezil >placebo | Phase_II | Efficacy and Safety Study... | NCT01137526 |
| Active | HCV Infection | >ABT-267 >Placebo >Blood Sample Collection >Cytochrome P450 inhibitor | Phase_I | Study of ABT-267 in Both ... | NCT01181427 |
| Active | Diabetes Mellitus | Comparison Study of Blood... | NCT01234727 | ||
| Active | Obesity | >Leuprolide >Testosterone | Influence of Male Hormone... | NCT01160328 | |
| Active | Coronary Artery Stenosis Coronary Arteriosclerosis Coronary Artery Disease Coronary Artery Restenosis Total Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia | >XIENCE V®/ XIENCE PRIME™ >CYPHER SELECT | Phase_IV | XIENCE V: SPIRIT WOMEN Su... | NCT01182428 |
| Active | Chronic Kidney Disease | >Zemplar | Phase_II Phase_III | Vitamin-D Receptor Activa... | NCT01204528 |
| Active | Hepatocellular Carcinoma | >temozolomide + ABT-888 | Phase_II | ABT-888 and Temozolomide ... | NCT01205828 |
| Active | Moderate to Severe Psoriasis | Clinical Effectiveness an... | NCT01156532 | ||
| Active | Lymphoma, Including Chronic Lymphocytic Leukemia Solid Tumors | >navitoclax >Rifampin | Phase_I | A Study to Assess the Eff... | NCT01121133 |
| Active | Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >AVJ-09-385 EECSS | Phase_III | A Clinical Evaluation of ... | NCT01115933 |
| Active | Chronic Coronary Occlusion Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >Thienopyridine (clopidogrel or prasugrel) | Phase_IV | XIENCE V® USA Dual Antip... | NCT01106534 |
| Active | Respiratory Syncytial Virus Infection | >Synagis (palivizumab) | Effectiveness of Synagis ... | NCT01107535 | |
| Active | HIV-1 | >Efavirenz or Nevirapine >Ritonavir-boosted lopinavir | Phase_IV | PI or NNRTI as First-line... | NCT01192035 |
| Active | Uveitis | >adalimumab >prednisone >prednisone >placebo | Phase_III | Efficacy and Safety of Ad... | NCT01124838 |
| Active | Essential Hypertension | Effectiveness and Patient... | NCT01127139 | ||
| Active | Solid Tumor Cancers | >veliparib >Temozolomide | Phase_II | To Evaluate the Safety of... | NCT01193140 |
| Active | Psoriatic Arthritis | >adalimumab (Humira) | Efficacy and Safety of Hu... | NCT01111240 | |
| Active | In-Stent Restenosis | >Coronary angioplasty using the paclitaxel-eluting balloon >Coronary angioplasty using the Everolimus-eluting stent | Phase_IV | RIBS IV (Restenosis Intra... | NCT01239940 |
| Active | Crohn's Disease | Metabolomic Analysis | NCT01105741 | ||
| Active | HIV Infection | A Comparison of Body Fat ... | NCT01159743 | ||
| Active | Arthritis, Rheumatoid Pain Fatigue | >adalimumab >Placebo | Pain Modulation in Rheuma... | NCT01197144 | |
| Active | HIV Infections | >lopinavir/ritonavir plus one nucleoside >lopinavir /ritonavir plus two nucleosides | Phase_III | Study of Lopinavir/ Riton... | NCT01237444 |
| Active | Sleep Disorder | >ABT-652 >Placebo | Phase_I | Safety, Tolerability, Pha... | NCT01124851 |
| Active | In-Stent Restenosis | >Coronary angioplasty using the paclitaxel-eluting balloon >Coronary angioplasty using the everolimus-eluting stent | Phase_IV | RIBS V (Restenosis Intra-... | NCT01239953 |
| Active | Human Immunodeficiency Virus | >Lopinavir/Ritonavir (Kaletra) | Study on the Usage, Dosin... | NCT01097655 | |
| Active | Crohn's Disease | >Treatment with Adalimumab | Small Bowel Mucosal Heali... | NCT01144156 | |
| Active | Ovarian Cancer | >ABT-888 >pegylated liposomal doxorubicin >temozolomide | Phase_II | A Trial of ABT-888 in Com... | NCT01113957 |
| Active | Uveitis | >adalimumab >prednisone >Adalimumab placebo >prednisone | Phase_III | Efficacy and Safety of Ad... | NCT01138657 |
| Active | Cardiovascular Diseases | Study of the Effectivenes... | NCT01200160 | ||
| Active | Schizophrenia | >ABT-126 >Placebo | Phase_II | Safety and Efficacy Study... | NCT01095562 |
| Active | Chronic Kidney Disease | >Paricalcitol | Phase_IV | The Effect of Paricalcito... | NCT01163162 |
| Active | Moderate to Severe Plaque Psoriasis | Effectiveness of Adalimum... | NCT01202565 | ||
| Active | Refractive Error | >STAR S4IR LASIK with iDesign Aberrometer | Performance and Acceptabi... | NCT01220466 | |
| Active | Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V EECSS >CYPHER SELECT PLUS SECSS | Phase_IV | XIENCE V Everolimus Eluti... | NCT01178268 |
| Active | Malnutrition | >Nutritional Supplement (Ensure Plus) | A Trial of Oral Nutrition... | NCT01190969 | |
| Active | Psoriasis | Special Investigation in ... | NCT01155570 | ||
| Active | Psoriasis Sleep Apnea, Obstructive | >Adalimumab >Placebo | Phase_IV | Efficacy and Safety of Ad... | NCT01181570 |
| Active | Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia B-cell Chronic Lymphocytic Leukemia Myelodysplasia | >ABT-348 | Phase_I | ABT-348 as Monotherapy to... | NCT01110473 |
| Active | Gastric Bypass Parathyroid Hormone | >Paricalcitol >Cholecalciferol >Placebo | Phase_III | Trial Of Paricalcitol and... | NCT01138475 |
| Active | Colorectal Cancer | >Veliparib | Phase_I | Evaluating the Safety and... | NCT01123876 |
| Active | Laparoscopy | >Sevoflurane VIMA >Propofol TCI >Sevoflurane >Propofol | Phase_IV | Compare Pharmaco-economic... | NCT01191476 |
| Active | Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >Percutaneous Coronary Intervention >CABG | Phase_III | EXCEL Clinical Trial | NCT01205776 |
| Active | Healthy Term Infants | >Milk based infant formula powder >Investigational Infant Formula #1 >Investigational Infant Formula #2 >Human Milk | Phase_III | Growth and Tolerance of H... | NCT01137877 |
| Active | Chronic Coronary Occlusion Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V® EECSS | XIENCE V® Everolimus Elu... | NCT01120379 | |
| Active | Ankylosing Spondylitis | >adalimumab >placebo >adalimumab | Phase_III | Efficacy and Safety of Ad... | NCT01114880 |
| Active | Rheumatoid Arthritis | Real Life Evaluation of R... | NCT01117480 | ||
| Active | Enthesitis Ankylosing Spondylitis Sacroiliitis Inflammatory Back Pain Juvenile Rheumatoid Arthritis | >adalimumab - blinded >placebo for adalimumab - blinded >Adalimumab - open label | Phase_III | A Study of the Efficacy a... | NCT01166282 |
| Active | Chronic Kidney Disease Secondary Hyperparathyroidism | Evaluation of Treatment W... | NCT01224782 | ||
| Active | Tracheitis Tracheobronchitis Bronchitis Chronic Bronchitis Community-Acquired Pneumonia (CAP) | Evaluation of Effectivene... | NCT01130883 | ||
| Active | Advanced Solid Tumors | >ABT-348 >ABT-348, carboplatin and gemcitabine >ABT-348 and docetaxel | Phase_I | ABT-348 as Monotherapy or... | NCT01110486 |
| Active | Spondyloarthritis Intestinal Inflammation | >Adalimumab | Intestinal Inflammation i... | NCT01174186 | |
| Active | Psoriasis | Evaluation of Humira Rete... | NCT01169987 | ||
| Active | Rheumatoid Arthritis | >Humira (adalimumab) >Methotrexate (MTX) | Phase_IV | A Study to Determine the ... | NCT01185288 |
| Active | Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | EXCEL Clinical Trial (Uni... | NCT01205789 | ||
| Active | Crohn's Disease | >adalimumab >prednisone >azathioprine | Phase_III | Efficacy and Safety of Tw... | NCT01235689 |
| Active | Acute Coronary Syndrome | >Immediate Invasive Management >Conventional Management | Direct Angioplasty for No... | NCT01172990 | |
| Active | Advanced or Metastatic Solid Tumors | >linifanib >ketoconazole | Phase_I | A Study to Assess the Eff... | NCT01114191 |
| Active | Secondary Hyperparathyroidism End Stage Renal Disease | A Study to Follow-up Pati... | NCT01149291 | ||
| Active | Rheumatoid Arthritis | Special Investigation (Fo... | NCT01163292 | ||
| Active | Respiratory Syncytial Virus Infections | >palivizumab (Synagis) | Prospective, Study for th... | NCT01155193 | |
| Active | Osteoarthritis Pain Morning Stiffness | Evaluation of the Effecti... | NCT01226095 | ||
| Active | HIV Infection | Evaluation of the Public ... | NCT01103596 | ||
| Active | Relapsed or Refractory Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone (Oral) >Dexamethasone (IV) >Elotuzumab | Phase_III | Study of Lenalidomide and... | NCT01239797 |
| Active | Rheumatoid Arthritis | Time to DMARD (Disease-Mo... | NCT01144598 | ||
| Active | Ischemic Heart Disease Coronary Artery Stenosis Chronic Coronary Total Occlusion Coronary Bypass Graft Stenosis | >MINI TREK RX 1.20 mm Coronary Dilatation Catheter | Phase_III | A Clinical Evaluation of ... | NCT01186198 |
| Active | Hepatitis C HCV Chronic Hepatitis C Hepatitis C Genotype 1 | >ABT-450/r >ABT-072 >ribavirin | Phase_II | A Study to Evaluate the S... | NCT01221298 |
| Active | Infant Newborn | >Human Milk >Investigational infant formula >Milk based standard infant formula | Phase_III | Effects of Early Nutritio... | NCT01300000 |
| Active | General Surgery | >sevoflurane | Evaluation of Volatile In... | NCT01282203 | |
| Active | Respiratory Syncytial Virus Infection | A One-Year Observation of... | NCT01297504 | ||
| Active | Coronary Artery Disease | Prospective Evaluation of... | NCT01299207 | ||
| Active | Crohn's Disease | >FITC-Adalimumab | Phase_I Phase_II | Safety and Tolerability o... | NCT01275508 |
| Active | Chronic Plaque Psoriasis | >Adalimumab - Low Dose >Adalimumab - Standard Dose >Methotrexate >Adalimumab - Open-Label | Phase_III | A Double Blind Study in P... | NCT01251614 |
| Active | Interstitial Cystitis | >Adalimumab >inactive drug | Phase_III | Efficacy Study of Adalimu... | NCT01295814 |
| Active | Contrast Media Induced Nephropathy (CIN) | >application of intravenous volume >oral fluid application | Neutrophil Gelatinase-ass... | NCT01292317 | |
| Active | Normal Contact Lens Wearers. | >Multi-purpose disinfecting solution >Clear Care >Opti-Free RepleniSH | Comparison of a New Abbot... | NCT01294917 | |
| Active | Cataract | >Tecnis Multifocal IOL >crystalens Accommodating IOL | Phase_IV | Comparison of Postoperati... | NCT01275118 |
| Active | Ankylosing Spondylitis Non-radiographic Axial Spondyloarthritis | German Spondyloarthritis ... | NCT01277419 | ||
| Active | Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis | Assessment of Pain Manage... | NCT01273519 | ||
| Active | Psoriasis | >Adalimumab | Phase_IV | Immediate Response With A... | NCT01265823 |
| Active | Mitral Regurgitation | >MitraClip Implant | MitraClip System in Austr... | NCT01301625 | |
| Active | Focus of Study is Cognitive Function During and After Hypoglycemia and to See if This Correlates Better With Blood or Interstitial Glucose Concentration. | >euglycemic and hypoglycemic clamp >interstitial fluid measurement for glucose concentration >continuous glucose monitor | Blood/Interstitial Glucos... | NCT01283126 | |
| Active | Angioplasty Chronic Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) | XIENCE V Everolimus Eluti... | NCT01249027 | |
| Active | Acute Decompensated Heart Failure Acute Kidney Injury | Acute Kidney Injury Neutr... | NCT01291836 | ||
| Active | Ischemic Heart Disease | >kissing balloon inflation >EES vs. SES | Comparison Between Everol... | NCT01266239 | |
| Active | Crohn's Disease | Special Investigation in ... | NCT01298648 | ||
| Active | Advanced Solid Tumors | >ABT-806 | Phase_I | A Study of ABT-806 in Sub... | NCT01255657 |
| Active | Chlamydia Infection Gonorrhea Sexually Transmitted Diseases | Phase_IV | Use of Abbott RealTime CT... | NCT01291264 | |
| Active | Intestinal Behçet's Disease | >Adalimumab | Phase_III | A Study of Adalimumab in ... | NCT01243671 |
| Active | Genital Endometriosis | Observational Program to ... | NCT01294371 | ||
| Active | Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis | Greek Study on Work Produ... | NCT01282372 | ||
| Active | Advanced Solid Tumors | >[14C]linifanib >ABT-869, linifanib | Phase_I | A Pharmacokinetic Study t... | NCT01286974 |
| Active | General Surgery | >sevoflurane | Evaluation of Volatile In... | NCT01282086 | |
| Active | Adenocarcinoma of the Prostate | >Androgen suppression plus radiation therapy | Phase_II | Adjuvant Androgen Suppres... | NCT01255891 |
| Active | Secondary Hyperparathyroidism Associated With Chronic Kidney Disease Stages 3-5 | Study to Assess Patient M... | NCT01265992 | ||
| Active | Kidney Failure, Chronic | Observational Study to Ev... | NCT01273597 | ||
| Active | Relapsed Indolent B-cell Lymphoma. | >TRU-016 >bendamustine + rituximab | Phase_I Phase_II | A Study of TRU-016 in Com... | NCT01317901 |
| Active | Rheumatoid Arthritis | Special Investigation in ... | NCT01346501 | ||
| Active | Ankylosing Spondylitis | Canadian Humira Post Mark... | NCT01387802 | ||
| Active | Heart Failure Hypogonadism | >testerone gel | Testosterone Therapy in H... | NCT01377103 | |
| Active | Advanced Solid Tumors | >ABT-806 >ABT-806i | Phase_I | An Evaluation of the Biod... | NCT01472003 |
| Active | Human Immunodeficiency Virus Infection | Treatment Perception of Q... | NCT01383005 | ||
| Active | Hidradenitis Suppurativa (HS) | >adalimumab >placebo >adalimumab | Phase_III | Efficacy and Safety Study... | NCT01468207 |
| Active | Rheumatoid Arthritis | Examination of the Effect... | NCT01482507 | ||
| Active | Type 2 Diabetes | >Paricalcitol >placebo | Phase_II | Salt Intake and Antiprote... | NCT01393808 |
| Active | Metastatic Breast Cancer | >Veliparib >Temozolomide >Carboplatin >Paclitaxel >Placebo | Phase_II | The Study Evaluating Effi... | NCT01506609 |
| Active | Diabetes Mellitus, Type 2 Diabetic Blood Glucose Monitoring | Continuous Glucose Monito... | NCT01390610 | ||
| Active | Secondary Hyperparathyroidism End-Stage Renal Disease | >Paricalcitol | Phase_III | A Study to Evaluate the S... | NCT01382212 |
| Active | Cystic Fibrosis Exocrine Pancreatic Insufficiency Pancreatic Diseases Digestive System Diseases | Special Investigation (Al... | NCT01427712 | ||
| Active | Carotid Artery Disease Stroke Amaurosis Fugax Transient Ischemic Attack (TIA) | >RX Acculink Carotid Stent System (RX Acculink) | Carotid Artery Stenting O... | NCT01445613 | |
| Active | Psoriasis | Canadian Humira Post Mark... | NCT01387815 | ||
| Active | Severe Crohn's Disease Anxiety | Reveal the Level of Anxie... | NCT01428115 | ||
| Active | Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer). | >ABT-700 >ABT-700 plus erlotinib >ABT-700 plus Oxaliplatin and Capecitabine | Phase_I | Study of ABT-700 in Subje... | NCT01472016 |
| Active | Chronic Hepatitis C Hepatitis C Hepatitis C Virus (HCV) | >ABT-450/r >ABT-333 >ribavirin | Phase_II | A Study to Evaluate the E... | NCT01306617 |
| Active | Cardiovascular Disease Diabetic Nephropathy | >Paricalcitol | Phase_IV | Effect of a Vitamin D Ana... | NCT01331317 |
| Active | Arthritis; Behcet | >Adalimumab (Humira) | Phase_III | Efficacy of Humira in Beh... | NCT01497717 |
| Active | Relapsing Remitting Multiple Sclerosis | >Daclizumab High Yield Process prefilled syringe | Phase_III | An Immunogenicity and Pha... | NCT01462318 |
| Active | Advanced Solid Tumors | >ABT-806 | Phase_I | An Extension Study of ABT... | NCT01406119 |
| Active | Diabetic Nephropathy Chronic Kidney Disease | >Atrasentan low dose group >Atrasentan high dose group >Atrasentan placebo group | Phase_II | Reducing Residual Albumin... | NCT01424319 |
| Active | Type 2 Diabetics Chronic Kidney Disease Protein in Urine | >ABT-614 >Placebo Comparator | Phase_I | A Study to Evaluate the S... | NCT01464320 |
| Active | Restenosis | Phase_III | Is There A LIfe for Drug ... | NCT01476020 | |
| Active | Stress Induced GI Bleeding C. Difficile Colitis | >Pantoprazole 40 mg IV daily will be given with tube feed. >Placebo and tube feed | Enteral Nutrition as Stre... | NCT01477320 | |
| Active | Rheumatoid Arthritis | Observational Study to Re... | NCT01383421 | ||
| Active | Arthritis, Juvenile Rheumatoid | Special Investigation (Al... | NCT01412021 | ||
| Active | Arthritis Rheumatoid | A Post-Marketing Observat... | NCT01464021 | ||
| Active | Pneumonia | >Experimental Oral Nutritional Supplement >No Product | Phase_III | Evaluation of an Oral Nut... | NCT01477723 |
| Active | Rheumatoid Arthritis | >Adalimumab | Phase_II | A Crossover Study of the ... | NCT01502423 |
| Active | Psoriasis Psoriatic Arthritis | Prevalence and Incidence ... | NCT01316224 | ||
| Active | Peripheral Vascular Disease | >Omnilink Eliteâ„¢ Peripheral Balloon-Expandable Stent System | Phase_III | Trial to Evaluate the Saf... | NCT01396525 |
| Active | Exocrine Pancreatic Insufficiency Pancreatic Diseases Digestive System Diseases | Special Investigation of ... | NCT01427725 | ||
| Active | Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma | >ABT-199 | Phase_I | A Phase 1 Study Evaluatin... | NCT01328626 |
| Active | Uveitis Juvenile Arthritis | >Anti-tumor necrosis factor alpha monoclonal antibody >placebo | Phase_II Phase_III | Effect of Adalimumab for ... | NCT01385826 |
| Active | Rheumatoid Arthritis | >adalimumab | Phase_IV | REstore Working Ability i... | NCT01405326 |
| Active | Advanced Parkinson's Disease | >ABT-SLV187 | Phase_II | Study of Safety, Tolerabi... | NCT01479127 |
| Active | Hepatitis C (HCV) Chronic Hepatitis C Hepatitis C Genotype 1 | >ABT-450/r >ABT-333 >ABT-267 >Ribavirin (RBV) | Phase_II | A Study of ABT-450 With R... | NCT01464827 |
| Active | Coronary Artery Disease (CAD) Chronic Total Occlusion (CTO) | >CTO Treatment Device | EXPERT CTO: Evaluation of... | NCT01435031 | |
| Active | Hidradenitis Suppurativa (HS) | >adalimumab >placebo >adalimumab | Phase_III | Efficacy and Safety Study... | NCT01468233 |
| Active | Crohn's Disease | Special Investigation on ... | NCT01464333 | ||
| Active | Advanced or Metastatic Solid Tumors | >linifanib | Phase_I | A Study Evaluating the Bi... | NCT01506934 |
| Active | Prostate Cancer | Observational Program to ... | NCT01320735 | ||
| Active | Critical Illness Enteral Feeding | >VITAL AF >Osmolite 1.2 | Tolerance and Efficacy of... | NCT01448135 | |
| Active | Uterine Fibroids, Heavy Uterine Bleeding | >placebo >elagolix, elagolix sodium >elagolix, elagolix sodium >elagolix, elagolix sodium >elagolix, elagolix sodium >Elagolix Dose 1 plus estradiol/norethindrone acetate | Phase_II | Safety and Efficacy Pre-M... | NCT01441635 |
| Active | Hepatitis C Virus | >ABT-450/r >ABT-267 >ribavirin | Phase_II | A Study to Evaluate ABT-4... | NCT01458535 |
| Active | Myocardial Infarction Multivessel Coronary Disease | >FFR-guided revascularisation strategy >staged revascularisation | Phase_IV | Comparison Between FFR Gu... | NCT01399736 |
| Active | Bronchitis | Outcome Study to Evaluate... | NCT01354938 | ||
| Active | HIV Infection | >Lopinavir/ritonavir (LPV/r) | Phase_II Phase_III | A Trial of Lopinavir/Rito... | NCT01338038 |
| Active | Folliculogenesis | >Elagolix >Elagolix >Elagolix >Elagolix >Elagolix Dose Regimen 5 >Elagolix Dose Regimen 6 | Phase_I | An Open-label Study of th... | NCT01403038 |
| Active | Lymphoma, B-Cell | >navitoclax >bendamustine >rituximab | Phase_II | A Study of Navitoclax in ... | NCT01423539 |
| Active | Crohn's Disease | >Adalimumab and Infliximab | Switching From Adalimumab... | NCT01338740 | |
| Active | Atherosclerosis Peripheral Artery Disease Peripheral Vascular Disease PAD Claudication Critical Limb Ischemia Lower Limb Disease Peripheral Arterial Occlusive Disease PAOD PVD | >Everolimus Eluting BVS | The ABSORB BTK (Below The... | NCT01341340 | |
| Active | Prostate Cancer | PROstate Cancer Imaging, ... | NCT01418040 | ||
| Active | Advanced Solid Tumors | >linifanib | Phase_I | To Compare Relative Bioav... | NCT01381341 |
| Active | Chronic Kidney Disease Secondary Hyperparathyroidism | Quality of Life in Greek ... | NCT01368042 | ||
| Active | Type 1 Diabetes Mellitus Retinal Diseases Diabetic Nephropathy | >Fenofibrate >Inert lactose placebo | Phase_III | A Trial in Adults With Ty... | NCT01320345 |
| Active | Alzheimer's Disease | >ABT-126 >Placebo | Phase_I | A Phase 1 Study of the Sa... | NCT01482845 |
| Active | Coronary Artery Disease | >Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS) >XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) | ABSORB PHYSIOLOGY Clinica... | NCT01308346 | |
| Active | Disorder of Transplanted Kidney Proteinuria Albuminuria | >Paricalcitol >Placebo | Phase_III | Efficacy and Safety of Pa... | NCT01436747 |
| Active | Stage 5 Chronic Kidney Diseases Moderate to Severe Secondary Hyperparathyroidism | >Paricalcitol | Phase_IV | A Prospective Open-Label ... | NCT01506947 |
| Active | Multiple Myeloma | >Elotuzumab >Bortezomib >Dexamethasone >Dexamethasone >Dexamethasone >Dexamethasone | Phase_II | Study of Bortezomib and D... | NCT01478048 |
| Active | Diabetic Nephropathy, Chronic Kidney Disease | >Atrasentan >Placebo | Phase_II | Evaluate the Efficacy and... | NCT01356849 |
| Active | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | >ABT-767 | Phase_I | Study of ABT-767 in Subje... | NCT01339650 |
| Active | Multiple Myeloma | >ABT-888/Bortezomib | Phase_I | Study of ABT-888 in Combi... | NCT01495351 |
| Active | Moderate to Severe Plaque Psoriasis Antibodies Monoclonals | Effectiveness of Adalimum... | NCT01401452 | ||
| Active | Corneal Astigmatism | >iFS Femtosecond Laser System | Phase_II | Safety and Effectiveness ... | NCT01348854 |
| Active | Rheumatoid Arthritis | >Observational study | Assess Structural Damage ... | NCT01476956 | |
| Active | Human Immunodeficiency Virus Infection | Drug Use Investigation of... | NCT01328158 | ||
| Active | Gastroenteritis Dehydration | >5% dextrose in normal saline | Study Investigating the U... | NCT01343758 | |
| Active | Hepatitis C Virus (HCV) Chronic Hepatitis C | >ABT-267 >Peginterferon alpha-2a (pegIFN) >Ribavirin (RBV) >Placebo | Phase_II | Study of ABT-267 in Treat... | NCT01314261 |
| Active | Coronary Artery Disease | >percutaneous coronary intervention ((RESOLUTE INTEGRITY stent) (XIENCE PRIME stent) | Phase_IV | LONG-DES VI (Drug Eluting... | NCT01489761 |
| Active | Respiratory Syncytial Virus Infection | >Palivizumab | Phase_III | Clinical Study of Paliviz... | NCT01466062 |
| Active | Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone >Dexamethasone >Elotuzumab (BMS-901608; HuLuc63) >Lenalidomide >Lenalidomide | Phase_I | Study of Elotuzumab in Co... | NCT01393964 |
| Active | Diabetes | >FreeStyle Navigator II Continuous Glucose Monitoring System | Navigator II Continuous G... | NCT01455064 | |
| Active | Osteoarthritis of the Knee | >ABT-652 >Placebo | Phase_II | A Study of ABT-652 in Com... | NCT01444365 |
| Active | Metastatic Pancreatic Cancer | >Veliparib and 5-FU and Oxaliplatin and Leucovorin | Phase_I Phase_II | ABT-888 With Modified FOL... | NCT01489865 |
| Active | Psoriasis | Quality of Life and Psych... | NCT01328366 | ||
| Active | Preterm Infants | >Experimental human milk fortifier >Control human milk fortifier | Phase_III | Evaluation of a Novel Hum... | NCT01373073 |
| Active | Smoldering Multiple Myeloma | >Elotuzumab (BMS-901608; HuLuc63) | Phase_II | Biomarker Study of Elotuz... | NCT01441973 |
| Active | Atherosclerosis Peripheral Vascular Disease Claudication | >ESPRIT BVS | ESPRIT I: A Clinical Eval... | NCT01468974 | |
| Active | Diabetes Mellitus | >Self monitoring blood glucose system >Self monitoring blood glucose system | Ease of Use of New Blood ... | NCT01432275 | |
| Active | Elderly | >Oral medical nutritional supplement >Experimental oral medical nutritional supplement with AN777 | Phase_III | Comparison of Medical Nut... | NCT01483976 |
| Active | Ankylosing Spondylitis Psoriatic Arthritis | Multi-country Post-Market... | NCT01474876 | ||
| Active | Dyslipidemias, Hypertriglyceridemia, Cardiovascular Diseases | >fenofibrate | Phase_IV | A Study to Evaluate Fenof... | NCT01462877 |
| Active | Secondary Hyperparathyroidism | Observational Program of ... | NCT01401478 | ||
| Active | Peripheral Artery Disease Peripheral Vascular Disease | >Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems | Absolute Pro® MOMENTUMâ„... | NCT01444378 | |
| Active | Ankylosing Spondylitis | Special Investigation in ... | NCT01329380 | ||
| Active | Diabetic Nephropathy Chronic Kidney Disease | >Atrasentan >Placebo | Phase_II | A Prospective, Double-Bli... | NCT01399580 |
| Active | Malnourished Stomach Neoplasms Gastrointestinal Stromal Tumors | >Ensure powder >Standard care | The Effects of Preoperati... | NCT01421680 | |
| Active | Coronary Artery Disease | >Abbott Vascular XIENCE PRIME Everolimus Eluting Coronary Stent System >Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System | ABSORB II Randomized Cont... | NCT01425281 | |
| Active | Secondary Hyperparathyroidism Hemodialysis | >paricalcitol >maxacalcitol | Phase_III | Comparison of Efficacy an... | NCT01341782 |
| Active | Recurrent, Epithelial Ovarian Cancer | >Veliparib | Phase_I Phase_II | Veliparib Monotherapy for... | NCT01472783 |
| Active | Prostate Cancer | Real Life Evaluation of L... | NCT01386684 | ||
| Active | Human Volunteers | >Nutritional Beverage >Nutritional Beverage >Nutritional Beverage | Phase_II | Nutrition Beverage Tolera... | NCT01464385 |
| Active | Gait or Balance Disorder Problems | >betahistine dihydrochloride >placebo | Phase_IV | The Cerebral Blood Flow (... | NCT01468285 |
| Active | Infant Newborn | >experimental infant formula with alternate protein source >Infant formula powder | Phase_III | Growth and Tolerance of Y... | NCT01380886 |
| Active | Rheumatoid Arthritis | Special Investigation in ... | NCT01346488 | ||
| Active | Pain | >150% Oral Morphine Equivalent (OME) >Clinical Judgment | Perioperative Pain Manage... | NCT01447888 | |
| Active | Rheumatoid Arthritis | A Study of Rheumatoid Art... | NCT01387789 | ||
| Active | Psoriasis | >Adalimumab | Cardiovascular Effects in... | NCT01320293 | |
| Active | Advanced Solid Tumors | >linifanib | Phase_I | An Extension Study of Lin... | NCT01413893 |
| Active | Healthy Premenopausal Women | >blood draws | Human Epididymis Protein ... | NCT01337999 | |
| Active | Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone >Dexamethasone >Dexamethasone >Elotuzumab (BMS-901608; HuLuc63) >Elotuzumab (BMS-901608; HuLuc63) | Phase_III | Phase III Study of Lenali... | NCT01335399 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Crohn's Disease | >Adalimumab | Phase_III | Study of the Human Anti-T... | NCT00105300 |
| Completed | HIV Infections | >Ritonavir >Nelfinavir mesylate | A Study of Ritonavir (ABT... | NCT00002201 | |
| Completed | Hypertension | >trandolapril/verapamil | Phase_IV | Russian Study of the Effi... | NCT00235001 |
| Completed | Healthy Volunteers | >ABT-614 | Phase_I | Exploratory Positron Emis... | NCT00788801 |
| Completed | Breast Cancer | >ABT-751 | Phase_II | A Study of ABT-751 in Pat... | NCT00063102 |
| Terminated | Osteoporosis | >Alendronate | Phase_III | Cancer and Osteoporosis R... | NCT00236002 |
| Terminated | Chronic Kidney Disease Stage 5 Left Ventricular Hypertrophy | >paricalcitol injection >placebo injection | Phase_III | The PRIMO II Study: Paric... | NCT00616902 |
| Completed | HCV Infection | >ABT-333 Tablet >Placebo >ABT-333 Capsule | Phase_I | Bioavailability of ABT-33... | NCT00895102 |
| Completed | Functional Dyspepsia | >Itopride (drug) | Phase_II Phase_III | Itopride in Functional Dy... | NCT00272103 |
| Completed | Acute Otitis Media | >cefdinir | Phase_II Phase_III | Safety and Efficacy Study... | NCT00645203 |
| Completed | Crohn's Disease | >Adalimumab | Phase_III | Remission in Subjects Wit... | NCT01070303 |
| Completed | Acute Heart Failure | >levosimendan >dobutamine | Phase_III | Survival of Patients With... | NCT00348504 |
| Terminated | Alzheimer's Disease | >ABT-089 >ABT-089 >ABT-089 >ABT-089 >ABT-089 >ABT-089 >placebo | Phase_II | Safety and Efficacy Study... | NCT00555204 |
| Completed | HCV Infection | >ABT-333 >Placebo | Phase_I | Study of ABT-333 in Both ... | NCT00696904 |
| Withdrawn | Solid Tumors | >ABT-869 >Tarceva | Phase_I | Study of ABT-869 in Combi... | NCT00754104 |
| Completed | Bipolar Disorder | >Divalproex Sodium (Depakote ER) | Phase_III | An Inpatient Study of the... | NCT00060905 |
| Completed | Peripheral Vascular Diseases | >Self-Expandable Peripheral Nitinol Stent | Phase_IV | ASSESS Study: Evaluation ... | NCT00180505 |
| Completed | Psoriasis | >adalimumab >placebo for adalimumab | Phase_II | Study of Two Dosing Sched... | NCT00645905 |
| [Trial of device that is ... | NCT00686205 | ||||
| Completed | Secondary Hyperparathyroidism Hemodialysis | >paricalcitol | Phase_II | Long-term Safety Study of... | NCT00701805 |
| Completed | Migraine | >divalproex sodium | Phase_III | Study Designed to Evaluat... | NCT00195806 |
| Completed | Hypercholesterolemia Dyslipidemia | >ABT-335 and Rosuvastatin Combination >ABT-335 >rosuvastatin calcium | Phase_III | A Multicenter Study Compa... | NCT00463606 |
| Completed | Type 2 Diabetes Mellitus | >standard enteral feeding product >Diabetes specific feeding product | Phase_II | Comparison of Enteral Pro... | NCT00544206 |
| Terminated | HIV-Associated Lipodystrophy HIV Infections | >poly-L-lactic acid >poly-L-lactic acid | Phase_IV | Facial Lipoatrophy Trial:... | NCT00126308 |
| Completed | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroids | >Asoprisnil >Asoprisnil | Phase_III | Safety of Treatment of Ut... | NCT00156208 |
| Completed | Carotid Artery Disease Carotid Stenosis Stroke Atherosclerosis | >Carotid artery stenting with filter (interventional) | Phase_IV | Emboshield® and Xact® P... | NCT00287508 |
| Completed | Secondary Hyperparathyroidism Chronic Kidney Disease | >Zemplar >42 Ca carbonate absorption via single tracer method >Calcijex | Phase_IV | Study to Evaluate the Eff... | NCT00073710 |
| Completed | HIV Infection | >Tenofovir DF >lopinavir/ritonavir with 2 Nucleoside RTIs | Phase_III | Efficacy of Simplified Tw... | NCT00234910 |
| Completed | Puberty, Precocious | >Leuprolide acetate | Phase_III | Study of Lupron Depot In ... | NCT00660010 |
| Completed | Atherogenic Dyslipidemia | >Lipitor >ABT335 >Niaspan | Phase_II | Combined Effects of Non-s... | NCT00728910 |
| Terminated | Alzheimer's Disease | >ABT-089 | Phase_II | A Study of the Long-Term ... | NCT00809510 |
| Completed | Asthma | >medical food with EPA and GLA, vitamins and minerals >medical food minus EPA and GLA, antioxidant vitamins/minerals | Phase_II | Effect of Medical Food on... | NCT01087710 |
| Completed | Obesity | >sibutramine | Phase_III | A Study of Sibutramine in... | NCT00261911 |
| Completed | Pediatric Epilepsy | >Depakote Delayed-Release/Depakote Sprinkle >Depakote ER | Phase_II | Pediatric Switch Study fo... | NCT00646711 |
| Completed | HCV Infection | >ABT-450 >ritonavir | Phase_I | Study in Healthy Adults t... | NCT00909311 |
| Completed | Pain | >Hydrocodone/Acetaminophen Extended Release >Hydrocodone/Acetaminophen >Placebo | Phase_II | Hydrocodone/Acetaminophen... | NCT00935311 |
| Completed | Renal Cell Cancer | >ABT-751 | Phase_II | A Study of ABT-751 in Pat... | NCT00073112 |
| Completed | Type II Diabetes Mellitus Mixed Dyslipidemia | >fenofibrate 160 mg and placebo >simvastatin 20 mg and placebo >fenofibrate 160 mg and simvastatin 20 mg | Diabetes and Combined Lip... | NCT00309712 | |
| Completed | Acute Otitis Media | >cefdinir (Omnicef) >azithromycin | Phase_IV | A Comparison of Safety an... | NCT00645112 |
| Completed | Partial Seizures | >Divalproex Sodium (Depakote Sprinkle Capsules) | Phase_III | A Study for Treatment of ... | NCT00102713 |
| Completed | Alcoholism Alcohol Related Disorders Mood Disorders | >divalproex sodium extended release | Phase_II Phase_III | Placebo Controlled Trial ... | NCT00202514 |
| Completed | Hypertension Diabetes | >trandolapril >trandolapril/verapamil >placebo >verapamil | Phase_IV | A Study for Prevention of... | NCT00235014 |
| Completed | Psoriasis | >placebo for adalimumab >adalimumab >adalimumab | Phase_II | Multicenter Study of the ... | NCT00645814 |
| Terminated | Rheumatoid Arthritis | >Humira (adalimumab) | Phase_IV | Evaluation of Quality of ... | NCT00761514 |
| Completed | Crohn's Disease | >Adalimumab | Phase_III | Long-term Safety and Tole... | NCT00195715 |
| Completed | Renal Insufficiency, Chronic | >paricalcitol capsule | Phase_III | Safety and Efficacy of Ze... | NCT00048516 |
| Completed | Myocardial Injury | >Sevoflurane | Phase_IV | Continuous Versus Repetit... | NCT00569816 |
| Completed | Healthy | >ABT-614 | Phase_I | A Study to Investigate th... | NCT00959816 |
| Withdrawn | HIV Infection Hepatitis C | >Kaletra (lopinavir/ritonavir) >Sustiva (efavirenz) >Truvada (emtricitabine/tenofovir disoproxil fumarate) | Phase_II | A Study Exploring an Indu... | NCT00121017 |
| Completed | HIV Infection | >HIV drug resistance tests based upon genotype testing | Phase_IV | Can Resistance Enhance Se... | NCT00262717 |
| Completed | Human Immunodeficiency Virus Infections | >lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) >lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) | Phase_III | Study of Lopinavir/Ritona... | NCT00358917 |
| Completed | Crohn's Disease | >adalimumab >adalimumab | Phase_III | Study of Adalimumab Treat... | NCT00409617 |
| Completed | Carotid Atherosclerosis Carotid Artery Disease | >Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system | Phase_II Phase_III | ACCULINK for Revasculariz... | NCT00180518 |
| Completed | HCV Infection | >ABT-072 >ketoconazole >Placebo | Phase_I | A Study in Healthy Adult ... | NCT00890318 |
| Completed | Diabetes Mellitus | >FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5 | Navigator 1.5 Accuracy St... | NCT01076218 | |
| Completed | HIV Infections | >Amprenavir/ritonavir >Saquinavir/ritonavir | Phase_II Phase_III | Amprenavir/Ritonavir or S... | NCT00038519 |
| Completed | Ankylosing Spondylitis | >adalimumab (D2E7) >placebo | Phase_III | Safety and Efficacy of Ad... | NCT00195819 |
| Completed | Respiration Disorders | >Sedation management protocol | Effectiveness of Sedation... | NCT00202319 | |
| Completed | Attention-Deficit/Hyperactivity Disorder | >ABT-089 >placebo | Phase_II | Safety and Tolerability S... | NCT00640419 |
| Completed | HIV Infections | >Lopinavir/ritonavir >Efavirenz >Lamivudine >Tenofovir DF | Phase_II | Effectiveness of ABT-378/... | NCT00038220 |
| Completed | Endometriosis | >Asoprisnil | Phase_II | A Long-Term Study to Eval... | NCT00160420 |
| Completed | Psoriasis | >adalimumab >MTX >placebo adalimumab, placebo MTX | Phase_III | Safety and Efficacy of Ad... | NCT00235820 |
| Completed | Chronic Kidney Disease, Stage 5 Secondary Hyperparathyroidism | >Zemplar® injection >Hectorol® injection | Phase_IV | A Study of Zemplar® Inje... | NCT00257920 |
| Completed | Bipolar Disorder | >divalproex ER >quetiapine | Phase_IV | Naturalistic Study, Compa... | NCT00397020 |
| Terminated | Schizophrenia | >ABT-925 | Phase_II | An Evaluation of the Safe... | NCT00412620 |
| Completed | Rheumatoid Arthritis | >adalimumab >placebo | Phase_III | Study of Adalimumab Admin... | NCT00647920 |
| Complete | HIV Infections | >Low dose Kaletra tablets | Comparison of Liquid Kale... | NCT00762320 | |
| Completed | Healthy Female Subjects | >ABT-263 >ABT-263 >ABT-263 | Phase_I | Assess the Oral Bioavaila... | NCT01053520 |
| Completed | Crohn's Disease | >adalimumab | Phase_III | Human Anti-TNF Monoclonal... | NCT00427921 |
| Completed | Diabetes Mellitus, Type 2 | >daily enteral nutritional product and/or behavioral changes | Phase_IV | An Intervention Program t... | NCT00543621 |
| Completed | Chronic Low Back Pain | >ABT-712 >ABT-712 placebo | Phase_III | Study to Evaluate the Saf... | NCT00763321 |
| Complete | Rheumatoid Arthritis Psoriatic Arthritis Ankylosing Spondylitis | >adalimumab (Humira) | Surveillance of Humira In... | NCT01083121 | |
| Completed | Human Immunodeficiency Virus Infections | >lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) >lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) >lopinavir/ritonavir (LPV/r) | Phase_III | Study of Lopinavir/Ritona... | NCT00262522 |
| Completed | Pain | >Extended-Release Hydrocodone/Acetaminophen (Vicodin® CR) >Immediate Release Hydrocodone/Acetaminophen (NORCO® ) | Phase_II | A Study Comparing Vicodin... | NCT00404222 |
| Completed | Psoriasis | >adalimumab | Phase_III | Open Label Study of Adali... | NCT00566722 |
| Completed | Rheumatoid Arthritis | >adalimumab >placebo >adalimumab | Phase_IV | Assessment of the Effect ... | NCT00649922 |
| Completed | Venous Insufficiency | >Venocur Triplex® >placebo | Phase_IV | Efficacy and Safety of th... | NCT00835822 |
| Completed | Healthy | >ABT-384 >Matching placebo to ABT-384 | Phase_I | A Study of Safety, Tolera... | NCT00968422 |
| Completed | HIV Infections | >Indinavir sulfate >Ritonavir | A Study of Ritonavir/Indi... | NCT00002223 | |
| Completed | Crohn's Disease | >Adalimumab (D2E7) | Phase_II | A Study of the Human Anti... | NCT00055523 |
| Completed | HIV Infection | >lopinavir/ritonavir >lamivudine/zidovudine | Phase_III | Efficacy and Safety of Ka... | NCT00234923 |
| Completed | Heart Failure, Congestive | >Levosimendan | Phase_III | Evaluation of Intravenous... | NCT00048425 |
| Completed | Carcinoma, Renal Cell | >ABT-510/Thrombospondin-1 mimetic | Phase_II | Safety and Efficacy of AB... | NCT00073125 |
| Completed | Schizophrenia | >Valproate | Phase_IV | Valproate in Late Life Sc... | NCT00194025 |
| Completed | Diabetic Neuropathic Pain | >ABT-894 >placebo | Phase_II | A Safety and Efficacy Stu... | NCT00548925 |
| Completed | Healthy | >cefdinir (Omnicef) >amoxicillin | Phase_IV | A Comparative, Single-Cen... | NCT00645125 |
| Completed | Asthma | >FlutiForm 250/10 >SKP-Fluticasone >Flovent Fluticasone HFA | Phase_III | A Study Comparing the Saf... | NCT00649025 |
| Completed | Pharmacokinetics | >ABT-335 >Atorvastatin >Ezetimibe | Phase_I | A Multiple-Dose Pharmacok... | NCT00681525 |
| Rheumatoid Arthritis | >adalimumab | Early Access Program of t... | NCT00650026 | ||
| Completed | Hepatitis C | >ABT-072 >Placebo | Phase_I | Single and Multiple Dose ... | NCT00982826 |
| Withdrawn | Bipolar Disorder | >Depakote >Lithium | Phase_IV | Safety Study of Depakote ... | NCT01075126 |
| Terminated | Heart Failure | >Levosimendan | Phase_III | Study of Blood Concentrat... | NCT00166127 |
| Completed | Bipolar Disorder Mania | >divalproex sodium extended release | Phase_IV | Study of Depakote ER for ... | NCT00181727 |
| Completed | Healthy | >ABT-436 >Placebo | Phase_I | A Study of Safety, Tolera... | NCT01050127 |
| Completed | Moderate to Severe Chronic, Non-Malignant Pain | >Hydrocodone/Acetaminophen | Phase_III | Long Term Safety and Tole... | NCT00195728 |
| Completed | Substance Abuse Bipolar Depression | >divalproex sodium ER >risperidone | Phase_IV | Divalproex ER vs. Risperi... | NCT00203528 |
| Completed | HIV Infections | >Fat Emulsion 2% >Fat Emulsion 20% | Long-Term Nutritional Sup... | NCT00002029 | |
| Completed | Bipolar Disorder | >Lithium >Divalproex | Phase_III | Lithium and Divalproex fo... | NCT00194129 |
| Completed | Attention-Deficit/Hyperactivity Disorder | >ABT-089 >Placebo | Phase_II | A Dose-Ranging, Cross-Ove... | NCT00391729 |
| Completed | Dyslipidemia Coronary Heart Disease Mixed Dyslipidemia | >ABT-335 and rosuvastatin calcium >ABT-335 and atorvastatin calcium >ABT-335 and simvastatin | Phase_III | Study to Evaluate the Lon... | NCT00300430 |
| Completed | Mixed Dyslipidemia | >ABT-335 >rosuvastatin calcium >simvastatin >atorvastatin calcium | Phase_III | A Year 2, Safety Extensio... | NCT00491530 |
| Terminated | Secondary Hyperparathyroidism Dialysis | >Calcitriol >Paricalcitol | Phase_IV | Efficacy and Safety of Pa... | NCT00664430 |
| Completed | Mycobacterium Avium-Intracellular Infection HIV Infections | >Ethambutol hydrochloride >Clarithromycin >Clofazimine | The Safety and Effectiven... | NCT00002331 | |
| Terminated | Partial Seizure Disorder | >Divalproex Sodium (Depakote® Sprinkle Capsules) | Phase_III | A Study of the Safety and... | NCT00067431 |
| Completed | HIV Infections | >Kaletra® (lopinavir/ritonavir) >Combivir® (lamivudine, zidovudine) >Sustiva® (efavirenz) | Phase_II | A Simplified Kaletra® (L... | NCT00075231 |
| Completed | Prostate Cancer | >Leuprolide acetate formulation A >Leuprolide acetate formulation B | Phase_III | A Study of Leuprolide 45 ... | NCT00626431 |
| Completed | Psoriasis | >ABT-874 >Methotrexate | Phase_III | A Study of Safety and Eff... | NCT00679731 |
| Completed | Healthy | >ABT-126 >Placebo | Phase_I | Pharmacokinetic and Explo... | NCT00912431 |
| Completed | Overweight | >Amino Acid Drink Mixture >Glucose drink | Phase_II | Glucose Tolerance in Heal... | NCT00974831 |
| Completed | HIV Infections | >Amprenavir/ritonavir >Saquinavir/ritonavir >Efavirenz | Phase_II | Amprenavir/Ritonavir, Saq... | NCT00038532 |
| Completed | Hypertension | >Trandolapril | Phase_IV | Canadian Study of Trandol... | NCT00233532 |
| Completed | Obesity | >sibutramine hydrochloride monohydrate >placebo >Diet and Exercise Counseling | Phase_III | A Long Term Study of Sibu... | NCT00234832 |
| Completed | Unstable Angina Non-ST-Elevation Myocardial Infarction | >iSTAT point of care analyzer | Phase_IV | Diagnosis and Treatment o... | NCT00276432 |
| Completed | Chronic Kidney Disease | >paricalcitol >paricalcitol >paricalcitol >paricalcitol | Phase_II | Paricalcitol Injection Ph... | NCT00646932 |
| Completed | HIV Infection | >Stopping nucleosides and continuing lopinavir/ritonavir monotherapy | Phase_IV | \"OK 2004 Study\" (Only K... | NCT00114933 |
| Completed | Endometriosis | >Asoprisnil >Asoprisnil >Asoprisnil >Placebo | Phase_II | A Study to Evaluate the S... | NCT00160433 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_II | Adalimumab in Adult Japan... | NCT00235833 |
| Terminated | Colorectal Neoplasms | >Eicosapentaenoic acid enriched nutritional supplement | Phase_IV | Study to Assess the Effec... | NCT00398333 |
| Completed | Diabetic Nephropathy Chronic Kidney Disease Stages 3 and 4 | >Zemplar (paricalcitol ) capsules >Zemplar (paricalcitol) capsules >Placebo | Phase_II | A Study of Paricalcitol C... | NCT00421733 |
| Completed | Attention-Deficit/Hyperactivity Disorder | >ABT-089 | Phase_II | Long Term Safety and Tole... | NCT00686933 |
| [Trial of device that is ... | NCT00933933 | ||||
| Completed | Head and Neck Cancer | >ABT-510 | Phase_I Phase_II | Study of ABT-510 (Thrombo... | NCT00113334 |
| Completed | Healthy Volunteers | >ABT-126 >Placebo | Phase_I | Pharmacokinetic Study of ... | NCT00959634 |
| Completed | End Stage Renal Disease Renal Failure | >PAL-40 Active >PAL-40 Placebo | Phase_III | Homocysteine Study (HOST) | NCT00032435 |
| Completed | HIV Infections | >Blood drawing to determine drug levels | Comparative Pharmacokinet... | NCT00179335 | |
| Completed | End Stage Renal Disease | >paricalcitol capsules | Phase_III | A Study to Evaluate the S... | NCT00646035 |
| Completed | HIV Infections | >Anti-HIV Immune Serum Globulin (Human) | Phase_I | Phase I Safety Study of A... | NCT00002036 |
| Completed | Mycobacterium Avium-Intracellular Infection HIV Infections | >Clarithromycin | The Safety and Effectiven... | NCT00002336 | |
| Completed | HIV Infections | >Lopinavir/ritonavir >Ritonavir | Phase_III | A Study of Two Different ... | NCT00038636 |
| Completed | Rheumatoid Arthritis | >Adalimumab >Methotrexate | Phase_III | Quality of Life Study Wit... | NCT00234936 |
| Completed | Healthy | >ABT-335 >rosuvastatin calcium >warfarin | Phase_I | Interaction Between ABT-3... | NCT00487136 |
| Completed | Diabetic Neuropathy, Painful Diabetic Polyneuropathy Neuralgia, Diabetic Diabetic Neuralgia Diabetic Neuropathies | >ABT-894 >ABT-894 >ABT-894 >placebo >duloxetine | Phase_II | Safety and Efficacy Study... | NCT00507936 |
| Completed | HCV Infection | >ABT-333 >Placebo | Phase_I | A Study to Assess the Saf... | NCT00909636 |
| Completed | Preterm Infants | >Preterm infant formulas and discharge formulas >Preterm infant formula with added soluble lipids | Phase_III | Nutritional Study in Pret... | NCT00707837 |
| Completed | Atherosclerosis Coronary Artery Disease | XIENCE V® EXCEED: Evalua... | NCT00731237 | ||
| Completed | Renal Insufficiency, Chronic | >paricalcitol | Phase_III | Safety and Efficacy of Ze... | NCT00048438 |
| Completed | Colorectal Cancer | >ABT-751 | Phase_II | A Study of ABT-751 in Pat... | NCT00073138 |
| Completed | Coronary Disease | >Multilink Visionâ„¢ Stent (CE-labeled) | Phase_IV | DaVinci Registry(Distinct... | NCT00243438 |
| Completed | Crohn's Disease | >adalimumab >adalimumab >placebo | Phase_II Phase_III | A Study of Adalimumab for... | NCT00445939 |
| Completed | Flushing | >Niacin and aspirin | Role of Prostaglandins on... | NCT00930839 | |
| Completed | Troponin Natriuretic Peptide, Brain Exercise Echocardiography | Myocardial Injury is Not ... | NCT00560040 | ||
| Completed | Hepatitis C | >ABT-072 | Phase_I | Evaluation of the Bioavai... | NCT00947440 |
| Completed | Migraine | >divalproex sodium | Phase_III | The Safety and Efficacy o... | NCT00195741 |
| Completed | Respiratory Distress Syndrome Pneumothorax/Pulmonary Intersticial Emphysema Chronic Lung Disease | >Very early surfactant and bubble NCPAP >bubble NCPAP | Phase_III | Very Early Surfactant and... | NCT00563641 |
| Completed | Cluster Headache | >Depacon IV and Depakote ER | An Open Label, Double Bli... | NCT00203242 | |
| [Trial of device that is ... | NCT00718042 | ||||
| Completed | Prostate Cancer | >atrasentan hydrochloride | Phase_III | Atrasentan in Treating Pa... | NCT00046943 |
| Completed | Prostate Cancer | >Atrasentan | Phase_III | A Study of Atrasentan in ... | NCT00036543 |
| Completed | Dyslipidemia Renal Insufficiency | >ABT-335 >Rosuvastatin | Phase_I | Safety Study to Evaluate ... | NCT00585143 |
| Completed | Acute Otitis Media | >cefdinir (Omnicef) >amoxicillin | Phase_IV | A Comparison of the Safet... | NCT00644943 |
| Completed | Mycobacterium Avium-Intracellulare Infection HIV Infections | >Clarithromycin | Phase_II | A Phase II Safety and Eff... | NCT00000644 |
| Completed | Ankylosing Spondylitis | >adalimumab (D2E7) >placebo | Phase_III | Human Anti-tumor Necrosis... | NCT00085644 |
| Completed | Uterine Fibroids Leiomyoma | >Asoprisnil >Asoprisnil >Placebo | Phase_II | A Study to Evaluate the E... | NCT00150644 |
| Terminated | Renal Artery Obstruction | >Renal Artery | Phase_III | Safety and Effectiveness ... | NCT00180544 |
| Completed | HCV Infection | >ABT-450 >ritonavir >placebo for ABT-450 >Placebo for ritonavir | Phase_I | Safety, Tolerability and ... | NCT00850044 |
| Completed | Rheumatoid Arthritis | >adalimumab >methotrexate | Phase_III | Adalimumab in Combination... | NCT00234845 |
| Completed | Photosensitive Epilepsy | >Valproic Acid >placebo | Effect of Valproic Acid C... | NCT00609245 | |
| Rheumatoid Arthritis | >adalimumab | Study of the Human Anti-T... | NCT00649545 | ||
| Terminated | Carcinoma, Non-Small-Cell Lung | >ABT-510/Thrombospondin-1 mimetic >Carboplatin/Taxol | Phase_II | Safety and Effectiveness ... | NCT00061646 |
| Completed | Endometriosis | >Asoprisnil >Asoprisnil >Asoprisnil >Placebo | Phase_II | A Study to Evaluate the S... | NCT00160446 |
| Terminated | Sarcoidosis | >Adalimumab | Phase_II | Trial of Adalimumab in Pr... | NCT00311246 |
| Completed | Chronic Kidney Disease Endothelial Dysfunction Inflammation Hypertension | >paricalcitol >Placebo | Study of Protective Effec... | NCT00428246 | |
| Completed | Secondary Hyperparathyroidism End Stage Renal Disease | >paricalcitol injection | Phase_IV | Safety and Effectiveness ... | NCT00053547 |
| Completed | Mania Mixed Mania | >Depakote ER >Depakote DR | Phase_IV | A Comparison Study of the... | NCT00334347 |
| Completed | Type 2 Diabetes | >herbal extract; root of woody shrub grown in India/Sri-Lanka | Phase_II Phase_III | Efficacy Study Testing He... | NCT00499148 |
| Completed | Healthy | >ABT-874 | Phase_I | Phase 1 BA Study, Single ... | NCT00870948 |
| Terminated | Alzheimer's Disease | >ABT-089 | Phase_II | A Study of the Safety and... | NCT00069849 |
| Completed | Mild to Moderate Uncomplicated Skin and Skin Structure Infections | >cefdinir >cephalexin | Phase_IV | A Study to Compare Cefdin... | NCT00234949 |
| Completed | Chronic Low Back Pain | >Extended release hydrocodone and acetaminophen (Vicodin CR) | Phase_III | A Study of Pain Relief in... | NCT00325949 |
| Completed | Chronic Plaque Psoriasis | >adalimumab >Calcipotriol/Betamethasone Ointment >placebo (vehicle ointment) | Phase_III | Adalimumab in Combination... | NCT00574249 |
| Completed | Heart Disease Cardiovascular Disease | >clarithromycin | Phase_III | The CLARICOR Trial: Effec... | NCT00121550 |
| Completed | Mood Disorder | >Valproic Acid and Depakote ER | Phase_IV | Comparing Compliance, Tol... | NCT00211250 |
| Completed | Crohn's Disease | >adalimumab | Phase_III | Treatment of the Human An... | NCT00338650 |
| Completed | Chronic Low Back Pain | >ABT-712 >ABT-712 placebo | Phase_III | Study to Evaluate the Saf... | NCT00761150 |
| Withdrawn | B-cell Chronic Lymphocytic Leukemia | >ABT-263 | Phase_II | Study Assessing the Safet... | NCT00918450 |
| Completed | Renal Insufficiency, Chronic | >paricalcitol | Phase_III | Safety and Efficacy of Ze... | NCT00048451 |
| Completed | Rheumatoid Arthritis | >Adalimumab | Phase_III | Study of Human Anti-TNF M... | NCT00049751 |
| Completed | Non-Small Cell Lung Cancer | >ABT-751 | Phase_II | A Study of ABT-751 in Pat... | NCT00073151 |
| Completed | HIV Infections Hyperlipidemia | >Rosuvastatin | Phase_II | Pharmacokinetic Study of ... | NCT00184951 |
| Completed | End Stage Renal Disease Hemodialysis Inflammatory Response Cardiovascular Disease | >paricalcitol | Phase_II | Immune Effects of Vitamin... | NCT00686751 |
| [Trial of device that is ... | NCT00961051 | ||||
| Completed | Epilepsy | >Divalproex >Divalproex | Comparison of Immediate v... | NCT00347152 | |
| Completed | Healthy Volunteers | >Macrolides (azithromycin or clarithromycin) | Selection of Antibiotic R... | NCT00354952 | |
| Completed | HIV Infections | >Lopinavir/ritonavir >Saquinavir mesylate >Lamivudine/zidovudine | Phase_II | Lopinavir/Ritonavir in Co... | NCT00043953 |
| Terminated | Bipolar Disorder | >Divalproex Sodium (Delayed-Release Tablets) >Divalproex Sodium (Extended-Release Tablets) >Olanzapine | Phase_IV | Depakote Monotherapy, Ola... | NCT00071253 |
| Completed | Coronary Artery Disease Everolimus Vascular Disease Myocardial Ischemia Coronary Artery Stenosis | >Coronary artery drug eluting stent placement >Coronary artery stent placement | Phase_III | SPIRIT FIRST Clinical Tri... | NCT00180453 |
| Completed | Healthy | >divalproex sodium | Phase_IV | Effects of Divalproex Sod... | NCT00287053 |
| Completed | Acute Bacterial Sinusitis (ABS) | >Clarithromycin >Amoxicillin | Phase_III | Comparative Study of the ... | NCT00644553 |
| Completed | Obesity Hypertension | >sibutramine >sibutramine >verapamil/trandolapril >metoprolol/HCT >felodipine/ramipril | Phase_III | Blood Pressure and Weight... | NCT00679653 |
| Completed | Prostatic Neoplasms | >Leuprolide acetate | Study of a 6-Month Sustai... | NCT00056654 | |
| Completed | Migraines | >divalproex sodium | Phase_III | A Phase III Open-Label, M... | NCT00195754 |
| Completed | Psoriasis | >Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks | Phase_II Phase_III | Adalimumab in Adult Japan... | NCT00338754 |
| Terminated | HIV Infection | >atazanavir >lopinavir/ritonavir | Phase_IV | Pharmacokinetic Study of ... | NCT00420355 |
| Terminated | Obesity Weight Loss | >placebo >sibutramine or placebo | Phase_III | Study to Examine the Long... | NCT00645255 |
| Completed | Dyslipidemias Hypercholesterolemia Coronary Heart Disease Hypertriglyceridemia | >ABT-143 >simvastatin | Phase_III | Safety and Efficacy Study... | NCT00812955 |
| Completed | Myopia Hyperopia Astigmatism | >Investigational MPS >Opti-Free RepleniSH | Phase_I Phase_II | Comparative Evaluation of... | NCT01024855 |
| Completed | Prostatic Neoplasms | >Atrasentan | Phase_III | Study of Atrasentan in Me... | NCT00036556 |
| Completed | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroids | >Asoprisnil >Asoprisnil | Phase_III | Study of Asoprisnil in th... | NCT00156156 |
| Completed | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroids | >Asoprisnil >Asoprisnil >Placebo | Phase_III | A Study to Evaluate of th... | NCT00152256 |
| Completed | Dyslipidemia Coronary Heart Disease Mixed Dyslipidemia | >ABT-335 >Simvastatin >Placebo | Phase_III | Evaluate Safety and Effic... | NCT00300456 |
| Completed | Rheumatoid Arthritis | >adalimumab >adalimumab | Phase_I | Pharmacokinetic and Safet... | NCT00650156 |
| Terminated | Alzheimer's Disease Dementia Behavioral Symptoms | >Divalproex ER >Quetiapine | Phase_IV | Safety and Efficacy of Di... | NCT00375557 |
| Terminated | Atherosclerosis | >extended release niacin >ezetimibe | Phase_IV | Comparative Study of the ... | NCT00397657 |
| Completed | Prostate Cancer Adenocarcinoma of the Prostate | >Atrasentan >Zoledronic Acid (Zometa) | Phase_II | Atrasentan and Zometa for... | NCT00181558 |
| Terminated | Rheumatoid Arthritis | >adalimumab (up to 9 months exposure) >methotrexate | Phase_IV | Open-Label Steroid Reduct... | NCT00233558 |
| Completed | Hypertension Metabolic Syndrome | >trandolapril/verapamil >(Hyzaar) losartan/hydrochlorothiazide | Phase_IV | Tarka vs. Hyzaar in Patie... | NCT00234858 |
| Terminated | Low Back Pain | >Interspinous process and dynamic stabilization (Wallis System) >Total Disc Replacement | Phase_III | Wallis Stabilization Syst... | NCT00484458 |
| Terminated | HIV Infections | >Raltegravir >Raltegravir | Phase_II | MK-0518 Intensification A... | NCT00614458 |
| Completed | Dyslipidemias Coronary Heart Disease Combined (Atherogenic) Dyslipidemia Mixed Dyslipidemia | >ABT-335 >placebo >atorvastatin >ezetimibe | Phase_III | Safety and Efficacy Study... | NCT00639158 |
| Completed | Healthy | >ABT-143 >ABT-335 >rosuvastatin | Phase_I | Comparison of the Bioavai... | NCT00826358 |
| Completed | Sarcoma, Soft Tissue | >ABT-510 - Thrombospondin-1 mimetic | Phase_II | Study Evaluating the Safe... | NCT00061659 |
| Completed | Leiomyoma | >Asoprisnil >Asoprisnil >Asoprisnil >Placebo | Phase_II | A Study to Evaluate the S... | NCT00160459 |
| Completed | Rheumatoid Arthritis | >adalimumab >methotrexate | Phase_III | Adalimumab Administered i... | NCT00235859 |
| Completed | Rheumatoid Arthritis Arthritis Joint Diseases | >Adalimumab (Humira) | Phase_IV | Humira in Rheumatoid Arth... | NCT00696059 |
| Completed | Healthy Volunteers | >ABT-102 >Placebo | Phase_I | A Safety, Tolerability an... | NCT00854659 |
| Completed | Ankylosing Spondylitis | >adalimumab (Humira) | Phase_III | An Open-Label Study to Ev... | NCT00478660 |
| Terminated | HIV Infections | >Anti-HIV Immune Serum Globulin (Human) >Zidovudine | Phase_II | The Safety and Effectiven... | NCT00000961 |
| Completed | HIV Infections | >Kaletra (lopinavir/ritonavir) >buprenorphine >Clinical evaluations/Blood draws | Pharmacokinetic Interacti... | NCT00571961 | |
| Completed | Coronary Artery Disease | >TriMaxx Coronary Stent placement | Phase_I | The TRIMAXX Coronary Sten... | NCT00596661 |
| Completed | Prostatic Neoplasms | >Atrasentan | Phase_II | Safety and Efficacy of At... | NCT00038662 |
| Completed | Bipolar Disorder | >Divalproex Sodium Extended-Release Tablets | Phase_III | An Outpatient Study of th... | NCT00067262 |
| Terminated | HIV Infection | >Lopinavir/Ritonavir | Phase_IV | Study of Adherence Effect... | NCT00234962 |
| Terminated | Hodgkin Disease Lymphoma, Non-Hodgkin Multiple Myeloma | >Leuprolide acetate >Placebo | Phase_II | A Study to Evaluate the A... | NCT00275262 |
| Terminated | Lung Cancer Non-Small Cell Lung Cancer | >ABT-751 >Placebo >Docetaxel | Phase_I Phase_II | A Phase 2 Study Evaluatin... | NCT00354562 |
| Completed | Psoriatic Arthritis | >Adalimumab | Phase_III | A Canadian Open-Label Stu... | NCT00427362 |
| Completed | Infant, Newborn | >milk protein formulas, varying carbohydrate/protein sources | Phase_II | Tolerance of Healthy Term... | NCT00705562 |
| Completed | Bipolar Disorder | >Enhanced Clinical Intervention | Bipolar Disorder Research... | NCT00211263 | |
| Withdrawn | Asthma | >Humira (adalimumab) | Phase_II | A Dose-Finding Study to E... | NCT00512863 |
| Completed | Schizophrenia | >Divalproex Sodium Extended-Release Tablets >Olanzapine >Risperidone | Phase_II | Depakote ER Plus an Atypi... | NCT00073164 |
| Completed | Healthy | >Alternate protein infant formula >Standard infant formula | Phase_II | Tolerance and Development... | NCT00465764 |
| Completed | Plaque Psoriasis | >ABT-874 >etanercept >placebo | Phase_III | Study Comparing the Effic... | NCT00691964 |
| Completed | Gastrointestinal Tolerance | >Experimental milk protein infant formula Process A >Experimental milk protein infant formula Process B >Experimental milk protein infant formula Process C >Experimental milk protein infant formula Process D >Experimental mil | Phase_III | Tolerance of Healthy Term... | NCT00977964 |
| Completed | Type 2 Diabetes Mellitus | >enteral nutritional formula >Diabetes specific enteral product | Phase_II | Comparison of Nutritional... | NCT00520065 |
| Completed | Sarcoma, Kaposi HIV Infections | >Ritonavir | Phase_II | The Safety and Effectiven... | NCT00002366 |
| Completed | HIV Infections | >Lopinavir/ritonavir >Tenofovir DF >Emtricitabine | Phase_III | Study of Lopinavir, Riton... | NCT00043966 |
| Completed | Spinal Muscular Atrophy | >Valproic Acid and Levocarnitine | Phase_II | Valproic Acid and Carniti... | NCT00227266 |
| Completed | Kidney Failure | >Paricalcitol | Phase_IV | Effect of Paricalcitol on... | NCT00294866 |
| Completed | Bipolar I Disorder, Manic or Mixed | >divalproex sodium | Phase_III | Evaluate the Safety of De... | NCT00195767 |
| Completed | Type 1 Diabetes | >Different insulin therapy at different time points | Ketoacidosis in Individua... | NCT00970567 | |
| Completed | Drug Interactions | >Vicodin® CR (extended-release hydrocodone/acetaminophen) | Phase_I | A Study to Evaluate the I... | NCT00429468 |
| Completed | Leiomyoma Menorrhagia Metrorrhagia | >Asoprisnil >Asoprisnil >Placebo | Phase_III | Treatment of Uterine Fibr... | NCT00152269 |
| Completed | HIV Infection | >MEMS cap | Phase_IV | Characterization of the A... | NCT00200369 |
| Completed | Mixed Dyslipidemia Coronary Heart Disease Dyslipidemia | >ABT-335 >Atorvastatin >Placebo | Phase_III | Evaluate Safety and Effic... | NCT00300469 |
| Completed | Plaque Psoriasis | >Adalimumab >Adalimumab >Adalimumab | Phase_III | Safety and Efficacy of Ad... | NCT00927069 |
| Completed | Psoriasis | >Humira (adalimumab) | Phase_III | A Canadian Open-Label Acc... | NCT00513370 |
| Completed | Rheumatoid Arthritis | >adalimumab >Placebo >adalimumab | Phase_III | Study Comparing 80 mg of ... | NCT00647270 |
| Terminated | HIV Tuberculosis | >lopinavir/ritonavir >rifabutin | Phase_I | A Bioavailability Study o... | NCT00743470 |
| [Trial of device that is ... | NCT00916370 | ||||
| Completed | Mycobacterium Avium-Intracellulare Infection HIV Infections | >Clarithromycin >Zidovudine >Didanosine | Phase_I | The Safety and Effectiven... | NCT00000971 |
| Completed | Multiple Sclerosis Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive | >ABT-874/Human monoclonal antibody against IL-12 | Phase_II | Safety and Effectiveness ... | NCT00086671 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_III | A Long Term Roll-Over Stu... | NCT00233571 |
| Completed | Hypertension Diabetes Proteinuria | >trandolapril/verapamil >Lotrel (amlodipine/benazepril) | Phase_IV | Tarka® vs. Lotrel® in H... | NCT00234871 |
| Completed | Lymphoma, Non-Hodgkin Hodgkin's Lymphoma | >ABT-510 - Thrombospondin-1 Mimetic | Phase_II | Study Evaluating the Safe... | NCT00061672 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_III | Adalimumab in Adult Japan... | NCT00235872 |
| Completed | HIV-1 Infection | >tenofovir/emtricitabine, lopinavir/ritonavir >antiretroviral treatment | Short Course Antiretrovir... | NCT01030172 | |
| Completed | Healthy | >Milk based formula A >#2 Standard formula >#3 Human Milk >Milk based formula C | Phase_II Phase_III | Tolerance of Healthy, Ter... | NCT00543673 |
| Completed | Acute Bacterial Sinusitis | >cefdinir (Omnicef) >levofloxacin | Phase_IV | Study of the Safety and E... | NCT00645073 |
| Complete | HIV-1 Infection | >Lopinavir/Ritonavir (Kaletra) | Surveillance of Kaletra i... | NCT01083173 | |
| Completed | Osteoarthritis | >Vicodin CR | Phase_III | A Study of Pain Relief in... | NCT00298974 |
| Completed | Type 2 Diabetes Obesity | >Glucerna SR | A Study to Evaluate the P... | NCT00631774 | |
| Completed | Healthy | >cefdinir (Omnicef) >azithromycin | Phase_IV | A Pediatric Taste Test St... | NCT00644774 |
| Completed | Asthma | >FlutiForm 250/10 ug >FlutiForm 100/10 ug >Oral Prednisone 10mg >Placebo | Phase_I | A Phase I Study in Asthma... | NCT00657774 |
| Complete | Crohn's Disease | >Adalimumab | Phase_III | Efficacy and Long Term Sa... | NCT00686374 |
| Completed | HIV Infections | >Fat Emulsion 2% >Fat Emulsion 20% | A Comparison of Two Types... | NCT00002275 | |
| Completed | Kidney Disease | >Zemplar Capsule | Phase_III | Zemplar® Capsule in Redu... | NCT00091975 |
| Terminated | HIV Infection | >Lopinavir/Ritonavir | Phase_IV | Safety of Lopinavir/Riton... | NCT00234975 |
| Completed | Schizophrenia Schizoaffective Disorder | >divalproex sodium ER >placebo | Phase_IV | Does The Addition Of Diva... | NCT00306475 |
| Completed | Spinal Muscular Atrophy | >Valproic Acid | Phase_I Phase_II | Study of Safety and Dosin... | NCT00374075 |
| Completed | NonDiabetes Glucose Variability CGM | >CGM System for Type 1 and Type 2 Diabetes Mellitus | Phase_II | Establishing Ambulatory G... | NCT00467675 |
| Completed | Psoriasis | >adalimumab | Phase_III | Efficacy and Safety of Ad... | NCT00195676 |
| Completed | Dry Eye | >(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 >Systane | Phase_II | Artificial Tears Study in... | NCT00607776 |
| Completed | Secondary Hyperparathyroidism Hemodialysis | >paricalcitol >maxacalcitol | Phase_II | Dose-response Study of Pa... | NCT00667576 |
| Completed | Metastatic Breast Cancer | >ABT-869 >paclitaxel >Placebo for ABT-869 | Phase_II | Phase 2 Study of ABT-869 ... | NCT00645177 |
| Completed | Dyslipidemia | >Niacin extended-release (NER) >Niacin extended-release (NER) placebo >Aspirin (ASA) >Aspirin (ASA) placebo | Phase_III | Evaluation of a Flushing ... | NCT00630877 |
| Completed | HIV Infections | >Lopinavir/Ritonavir >Lamivudine >Stavudine | Phase_I Phase_II | ABT-378/Ritonavir in Comb... | NCT00004578 |
| Completed | Hypocalcemia | >paricalcitol injection (Zemplar) >Effects on calcium regulation >Administration of elemental Ca during hypocalcemic ICU pts. | Phase_II | A Study to Examine the Us... | NCT00053378 |
| Completed | Prostate Cancer Adenocarcinoma | >Atrasentan | Phase_II Phase_III | A Long Term Safety Study ... | NCT00127478 |
| Completed | Arthritis Psoriatic | >adalimumab >placebo for adalimumab | Phase_III | Study of the Safety and E... | NCT00646178 |
| Terminated | Non Small Cell Lung Cancer Advanced Lung Cancer | >ABT-751 and Carboplatin | Phase_I Phase_II | Pharmacokinetic & Pharmac... | NCT00735878 |
| Completed | Healthy | >ABT-143 >ABT-335 >rosuvastatin | Phase_I | Comparison of the Bioavai... | NCT00808678 |
| Completed | Severe Respiratory Syncytial Virus Infection | Retrospective Palivizumab... | NCT01075178 | ||
| Completed | Crohn's Disease | >Adalimumab | Phase_III | Adalimumab for the Induct... | NCT00077779 |
| Completed | Vascular Closure | Groin Complications Post ... | NCT00842179 | ||
| Completed | HIV Infections | >Lopinavir/Ritonavir >Nevirapine | Phase_I | A Study of ABT-378/Ritona... | NCT00004580 |
| Completed | Bipolar I Disorder | >Divalproex Sodium (Depakote ER) | Phase_III | A Study for the Treatment... | NCT00195780 |
| Completed | Sepsis Severe Sepsis Septic Shock | >Eicosapentaenoic acid, Gamma-Linolenic Acid and Antioxidant Vitamins >Standard ICU enteral diet, isocaloric to the study diet | Phase_IV | The Effects of Eicosapent... | NCT00329680 |
| Completed | Moderate to Severe Plaque Psoriasis | >ABT-874 >etanercept >placebo | Phase_III | Study Comparing the Effic... | NCT00710580 |
| Completed | Adverse Events Pharmacokinetic Variables | >ABT-143 >ABT-335 and rosuvastatin | Phase_I | Study to Compare the Bioa... | NCT00728780 |
| Completed | Immunosuppression | >Virosomal influenza vaccine >Subunit influenza vaccine | Phase_IV | Influenza Vaccination in ... | NCT00783380 |
| Completed | HIV Infections | >Lopinavir/Ritonavir >Nevirapine | Phase_III | A Study to Compare Two An... | NCT00004581 |
| Completed | Kidney Failure, Chronic | >Zemplar | Phase_IV | Study to Compare Initial ... | NCT00091481 |
| Completed | Leiomyoma Menorrhagia Metrorrhagia | >Asoprisnil >Asoprisnil >Placebo | Phase_III | A Study to Evaluate the S... | NCT00160381 |
| Terminated | Obesity Morbid Obesity | State of Obesity Care in ... | NCT00328081 | ||
| Completed | Diabetes Glucose Variability CGM | >CGM System for Type 1 and Type 2 Diabetes Mellitus | Phase_I | Develop Novel Methods to ... | NCT00465881 |
| Completed | Diabetes Mellitus, Type 2 | >Nutritional Formula >Usual diet >Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars. | Phase_III | Effects of Nutritional Pr... | NCT00753181 |
| Completed | Diabetes Mellitus | >FreeStyle Navigator Continuous Glucose Monitoring System | Clinical Evaluation of th... | NCT00920881 | |
| Completed | HCV Infection | >ABT-450 >ritonavir >Placebo for ABT-450 >Placebo for ritonavir | Phase_I | Study in Healthy Adults t... | NCT00931281 |
| Completed | Amenorrhea Postmenopause | >Asoprisnil/Premarin >Asoprisnil/Premarin >Asoprisnil/Premarin >Placebo and Premarin | Phase_II | A Study to Evaluate the S... | NCT00152282 |
| Completed | Leiomyoma | >Asoprisnil | Phase_II | A Long-Term Safety Study ... | NCT00156182 |
| Completed | Borderline Personality Disorder | >Depakote ER | Depakote ER in Borderline... | NCT00222482 | |
| Completed | HIV Infection | >Nucleoside analogue switch | SNAP: Switching Nucleosid... | NCT00225082 | |
| Completed | Dyslipidemia Coronary Heart Disease Mixed Dyslipidemia | >ABT-335 >Rosuvastatin Calcium >Placebo | Phase_III | Evaluate Safety and Effic... | NCT00300482 |
| Completed | HIV Infections | >Lopinavir/Ritonavir >Nelfinavir mesylate >Lamivudine >Stavudine | Phase_III | A Phase III Study Compari... | NCT00004583 |
| Completed | Coronary Artery Disease | >Guidant GALILEO Intravascular Radiotherapy System | Phase_IV | Vision II: Evaluation of ... | NCT00180583 |
| Completed | Crohn's Disease | >adalimumab >placebo >adalimumab | Phase_III | Effects of Adalimumab on ... | NCT00348283 |
| Completed | Pain | >Extended-Release Hydrocodone/Acetaminophen (Vicodin® CR) | Phase_II | A Study Comparing the Ana... | NCT00404183 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_III | A Study to Assess the Saf... | NCT00448383 |
| Completed | Binge Eating Disorder Obesity | >sibutramine | Phase_III | A Study to Examine the Ef... | NCT00402584 |
| Completed | HIV Infections | >Increased dose of Kaletra | Phase_IV | BOOST: Study of Increased... | NCT00414284 |
| Completed | Psoriatic Arthritis | >adalimumab | Phase_III | Safety and Efficacy Study... | NCT00235885 |
| Terminated | Attention-Deficit/Hyperactivity Disorder | >ABT-089 | Phase_II | A Safety and Tolerability... | NCT00554385 |
| Completed | Attention-Deficit/Hyperactivity Disorder | >ABT-089 >Placebo | Phase_II | Safety, Tolerability and ... | NCT00640185 |
| Completed | Crohn's Disease | >Clarithromycin >Placebo | Phase_III | Clarithromycin in Active ... | NCT00269386 |
| Completed | Plaque Psoriasis | >Placebo >ABT-874 >ABT-874 | Phase_III | A Study Comparing the Saf... | NCT00570986 |
| Completed | Arthritis Psoriatic | >adalimumab >placebo for adalimumab | Phase_II | Study of the Safety and E... | NCT00646386 |
| Completed | Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). | >clarithromycin extended-release tablets >clarithromycin immediate-release tablets | Phase_III | Comparative Study of 5 Da... | NCT00645086 |
| Completed | Peripheral Vascular Disease Cardiovascular Disease | >Vessel Closure (StarCloseâ„¢) | Phase_IV | RISE: A Clinical Evaluati... | NCT00736086 |
| Completed | Psoriasis | >adalimumab | Phase_III | Efficacy and Safety of Ad... | NCT00237887 |
| Completed | Psoriasis | >Humira >placebo | Phase_IV | Controlled Study of Humir... | NCT00735787 |
| Completed | Hepatitis C | >ABT-072 >placebo | Phase_I | A Study of ABT-072 in Hea... | NCT00752687 |
| Completed | Obesity | >sibutramine hydochloride monohydrate | Phase_IV | A Phase IV, Multi-Center,... | NCT00234988 |
| Completed | Hyperlipidemia Mixed Dyslipidemia | >Niacin ER/Simvastatin Tablets >atorvastatin | Phase_III | An Open-Label Study to Co... | NCT00465088 |
| Completed | Diabetes Mellitus Type 2 | >Adult enteral formula | Phase_III | Glucose/Insulin Responses... | NCT00540488 |
| Completed | Psoriatic Arthritis | >Human anti-TNF monoclonal antibody/adalimumab | Phase_III | Safety and Efficacy of Ad... | NCT00195689 |
| Completed | Non-Small-Cell Lung Cancer Lung Cancer NSCLC | >ABT-751 >pemetrexed >placebo | Phase_I Phase_II | A Phase 2 Study Evaluatin... | NCT00297089 |
| Rheumatoid Arthritis | >adalimumab | Open Label Study to Asses... | NCT00650390 | ||
| Completed | HCV Infection | >ABT-333 >ketoconazole >placebo | Phase_I | A Study in Healthy Adult ... | NCT00768690 |
| Completed | HCV Infection | >ABT-333 >Placebo >peginterferon alfa-2a >Ribavirin | Phase_II | A Study to Evaluate the S... | NCT00851890 |
| Completed | HCV Infections | >ABT-333 >Placebo | Phase_I | A Study of Single Dose of... | NCT00919490 |
| Completed | Pain | >Hydrocodone/Acetaminophen (Vicodin® CR) | Phase_II | A Study Comparing the Ana... | NCT00404391 |
| Completed | Attention-Deficit/Hyperactivity Disorder ADHD | >ABT-894 >atomoxetine >placebo | Phase_II | A Dose-Ranging Study of t... | NCT00429091 |
| Completed | Attention Deficit Hyperactivity Disorder | >ABT-089 | Phase_II | A Safety and Tolerability... | NCT00443391 |
| Completed | Healthy | >cefdinir (Omnicef) >amoxicillin | Phase_IV | Pediatric Taste Test Stud... | NCT00644891 |
| Completed | Psoriasis | >adalimumab >adalimumab >adalimumab | Phase_II | Study of the Safety and E... | NCT00646191 |
| Completed | Rheumatoid Arthritis | >adalimumab >adalimumab >adalimumab >placebo | Phase_II Phase_III | A Study of Adalimumab in ... | NCT00647491 |
| Completed | Obesity | >Sibutramine >Placebo | Phase_III | Efficacy and Safety Study... | NCT00677391 |
| Completed | Aged | >Ad lib diet and Control placebo >Ad lib diet and An 777 >Ad lib diet/ placebo/ exercise >Ad lib diet; AN 777; exercise | Phase_II Phase_III | Evaluation of AN777 in El... | NCT00798291 |
| Completed | Hypertension Coronary Artery Disease | >Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ) >Atenolol/HCTZ/Trandolapril | Phase_IV | INVEST: INternational VEr... | NCT00133692 |
| Completed | Atherosclerotic Disease, Carotid | >RX ACCULINK(TM) Carotid Stent System and RX ACCUNET(TM) Embolic Protection System | Post-Approval Study of th... | NCT00180492 | |
| Completed | Pain | >Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) | Phase_III | A Study of Extended-Relea... | NCT00402792 |
| Completed | Psoriasis | >adalimumab >placebo for adalimumab | Phase_II | Extension Study of Two Do... | NCT00645892 |
| Completed | Dyslipidemia | >niacin extended-release (NER) >aspirin (ASA) >aspirin placebo (ASA Pbo) | Phase_III | Study to Evaluate the EFF... | NCT00626392 |
| Completed | Mild to Moderate Asthma | >fluticasone propionate, formoterol fumarate >fluticasone propionate, formoterol fumarate >fluticasone propionate, formoterol fumarate | Phase_II | Single-Dose Crossover Stu... | NCT00734292 |
| Completed | Hyperlipidemia | >fenofibrate >ezetimibe >atorvastatin | Phase_III | A 16 Week Comparative Stu... | NCT00195793 |
| Completed | Metabolic Syndrome X Insulin Resistance | >fenofibrate >niacin >rosiglitazone | Phase_IV | Study of Niacin and Rosig... | NCT00304993 |
| Complete | Hypoalbuminemia Protein-Energy Malnutrition Inflammation Oxidative Stress Chronic Kidney Disease (CKD) Hemodialysis | >pentoxiphylline >Nepro >anti-inflammatory module (similar to Oxepa) >Placebo pill imitating pentoxiphylline >Placebo to imitate Nepro >Placebo to imitate anti-inflammat | Phase_III | Anit-Inflammatory and Ant... | NCT00561093 |
| Completed | Rheumatoid Arthritis | >Adalimumab | Phase_III | Self-injection of Adalimu... | NCT00603993 |
| Completed | Pharmacokinetic Variables | >ABT-143 ( rosuvastatin calcium and fenofibric acid ) >ABT-143 (rosuvastatin calcium and fenofibric acid ) | Phase_I | Assessment of the Effect ... | NCT00719693 |
| Completed | Healthy | >ABT-335 | Phase_I | Comparison of Fenofibric ... | NCT00839293 |
| Completed | Schizophrenia | >ABT-288 >Placebo | Phase_I | A Multiple Dose Study of ... | NCT00888693 |
| Complete | Ulcerative Colitis | >adalimumab | Phase_III | Long-term Open-label Safe... | NCT00573794 |
| Completed | Sepsis | A Simple Clinical Tool to... | NCT00599794 | ||
| Completed | Postmenopause | >Asoprisnil/Premarin | Phase_II | A Long-Term Study to Eval... | NCT00152295 |
| Completed | Leiomyoma Menorrhagia Metrorrhagia | >Asoprisnil >Asoprisnil | Phase_III | Study to Evaluate the Saf... | NCT00156195 |
| Completed | Bipolar Disorder Mania Substance Abuse Substance Dependence | >Divalproex ER | Phase_IV | Depakote ER Therapy for M... | NCT00208195 |
| Withdrawn | Coronary Artery Disease | >Multi-Link Frontier Coronary Stent System | Phase_IV | Frontier Registry II Bifu... | NCT00286195 |
| Completed | Adverse Events Pharmacokinetic | >ABT-143 >ABT-335 >Rosuvastatin | Phase_I | Study to Compare the Bioa... | NCT00681395 |
| Completed | Hypertension | Effectiveness and Tolerab... | NCT01079195 | ||
| Completed | Psoriasis | >Anti IL-12 monoclonal antibody/ABT-874 >placebo | Phase_II | Efficacy and Safety of AB... | NCT00292396 |
| Completed | Hypertriglyceridemia With the Metabolic Syndrome | >Fenofibrate (drug) | Effects of Micronized Fen... | NCT00422396 | |
| [Trial of device that is ... | NCT00783796 | ||||
| Completed | Hidradenitis Suppurativa | >adalimumab | Phase_II | To Assess the Efficacy an... | NCT00827996 |
| Hepatitis C Virus Infection | >Blood sample collection | Phase_II | A Follow-up Study to Asse... | NCT00872196 | |
| Completed | Crohn's Disease | >adalimumab >adalimumab >placebo | Phase_II | Remission in Subjects Wit... | NCT00055497 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_IV | Efficacy of HUMIRA in Sub... | NCT00234897 |
| Completed | Attention-Deficit/Hyperactivity Disorder | >ABT-089 >atomoxetine >placebo | Phase_II | A Safety and Efficacy Stu... | NCT00528697 |
| Terminated | End-Stage Kidney Disease | >Zemplar (paricalcitol injection) >Calcijex | Phase_IV | Evaluate the Survival Ben... | NCT00062699 |
| Completed | Prostatic Neoplasms | >daily Xray volume imaging for planning radiotherapy | Phase_II | Xray Volume Imaging (Cone... | NCT00188799 |
| Terminated | HIV Infections Kaletra | >lopinavir/ritonavir >lopinavir /ritonavir | Phase_IV | Safety and Efficacy of Ka... | NCT00648999 |
| Completed | Alzheimer's Disease | >ABT-126 | Phase_I | A Safety and Tolerability... | NCT00867399 |
| Completed | Diabetes Mellitus, Type 2 | >Experimental nutritional formula #M979 >Standard food | Phase_III | Four-Hour Evaluation of a... | NCT01188200 |
| Completed | Influenza | >Trivalent influenza subunit vaccine Influvac | Phase_III | Annual Study to Investiga... | NCT01146015 |
| Completed | Coronary Disease Coronary Artery Disease Coronary Restenosis | >TAXUS® Liberté™ >XIENCE V® EECSS | Phase_IV | SPIRIT V: A Clinical Eval... | NCT01171820 |
| Completed | Rheumatoid Arthritis | >adalimumab | Phase_III | A Study of Adalimumab Whe... | NCT01231321 |
| Completed | Corneal Staining | >Biotrue MPS >Investigational MPS | Phase_III | Short-Term Evaluation of ... | NCT01240122 |
| Complete | Uveitis | >adalimumab | Phase_III | A Study of the Long-term ... | NCT01148225 |
| Complete | Dry Eye Disease | Phase_IV | TearLab Refractive Surger... | NCT01176045 | |
| Completed | Hypogonadism | >Testosterone Gel 1.62% >Testosterone Gel 1.62% | Phase_I | Pharmacokinetic and Compa... | NCT01133548 |
| Completed | Healthy | >Sampling Rate | Phase_I | Exploratory Biomarker Stu... | NCT01126567 |
| Completed | HIV Infections Hepatitis B Hepatitis C | >Lopinavir/Ritonavir (Kaletra) | Long-term Effectiveness a... | NCT01153269 | |
| Complete | Anesthesia, General | Estimate the Behavior of ... | NCT01199471 | ||
| Terminated | Cognition Disorders | >SLV354 capsules >SLV354 capsules >SLV354 capsules >SLV354 capsules >SLV354 capsules >SLV354 capsules >SLV354 capsules >SLV354 capsules >Placebo capsules >SLV354 | Phase_I | This is a Single Ascendin... | NCT01133574 |
| Completed | Respiratory Tract Infections | >Clarithromycin (Klacid SR) | Evaluation of the Treatme... | NCT01095978 | |
| Completed | Tracheitis Tracheobronchitis Bronchitis Chronic Bronchitis Community-Acquired Pneumonia | Evaluation of the Treatme... | NCT01108185 | ||
| Completed | Pharmacokinetics | >Testosterone Gel 1.62% | Phase_I | An Open-Label Study of Se... | NCT01130298 |
| Complete | Moderate to Severe Plaque Psoriasis | >briakinumab | Phase_I | Open Label, Single Dose, ... | NCT01260844 |
| Completed | Rheumatoid Arthritis | >Adalimumab | Phase_IV | The Effect of Adalimumab ... | NCT01270087 |
| Completed | Type 1 Diabetes Mellitus | >Closed-Loop System >Open-Loop System | Feasibility Study of a Mo... | NCT01418703 | |
| Completed | HIV-1 Patients | Multicountry, Multicenter... | NCT01379703 | ||
| Completed | Major Depressive Disorder | >ABT-436 >Matching Placebo | Phase_I | Safety and Pharmacodynami... | NCT01380704 |
| Completed | Coronary Disease Coronary Artery Disease Coronary Artery Stenosis Coronary Artery Restenosis | >Coronary artery placement of a drug-eluting stent | Phase_IV | EXecutive Registry: Evalu... | NCT01310309 |
| Complete | Normative Data Study of Joints of Healthy Children | Acquisition of Normative ... | NCT01387009 | ||
| Completed | Hypogonadal Males | >ABT-SLV361 >placebo | Phase_I | Study of the Safety, Tole... | NCT01346319 |
| Completed | Diabetes Mellitus, Type 2 | >No breakfast/beverage only >Breakfast >10004RF | Phase_II Phase_III | Effect of Nutritional Pro... | NCT01324921 |
| Completed | Acute Pain | >hydrocodone / acetaminophen extended release >Placebo | Phase_II | Acute Pain Study Followin... | NCT01333722 |
| Completed | Chronic Low Back Pain | >hydrocodone / acetaminophen extended release >Placebo | Phase_II | Phase 2 Chronic Low Back ... | NCT01364922 |
| Completed | Advanced Solid Tumors | >Linifanib >Rifampin | Phase_I | Effect of Rifampin on the... | NCT01401933 |
| Complete | Percutaneous Coronary Intervention Ischemic Symptoms | >Transradial PCI >Transfemoral PCI | SAFE-PCI for Women | NCT01406236 | |
| Completed | Diabetic Neuropathic Pain | >ABT-639 >pregabalin >Placebo | Phase_II | A Multicenter Study Compa... | NCT01345045 |
| Terminated | Respiratory Distress Syndrome,Adult Acute Lung Injury | >Enteral nutrition with fatty acids >Standard Enteral Nutrition | Phase_III | Effect of Enteral Nutriti... | NCT01464853 |
| Completed | Type 1 Diabetes Mellitus | >Open-Loop >Closed-Loop | Hypoglycemia Prevention A... | NCT01390259 | |
| Completed | Burns | >Nutritional Supplement >Hospital food | Phase_III | Effect of Nutritional Sup... | NCT01464866 |
| Completed | Parkinson Disease | >Levodopa-Carbidopa | Phase_I | A Pharmacokinetic Study o... | NCT01484990 |
| Completed | Diabetes Mellitus, Type 2 | >Carbohydrate placebo >Nutritional ingredient >#1 Nutritional ingredient +Fiber >#2 Nutritional ingredient + Fiber >#3 Nutritional ingredient + Fiber | Phase_II Phase_III | Post Prandial Glucose Con... | NCT01326299 |